Precise	O
alignment	B-DNA
of	I-DNA
sites	I-DNA
required	O
for	O
mu	B-DNA
enhancer	I-DNA
activation	O
in	O
B	B-cell_type
cells	I-cell_type
.	O

The	O
lymphocyte-specific	B-DNA
immunoglobulin	I-DNA
mu	I-DNA
heavy-chain	I-DNA
gene	I-DNA
intronic	I-DNA
enhancer	I-DNA
is	O
regulated	O
by	O
multiple	O
nuclear	B-protein
factors	I-protein
.	O

The	O
previously	O
defined	O
minimal	B-DNA
enhancer	I-DNA
containing	O
the	O
muA	B-DNA
,	I-DNA
muE3	I-DNA
,	I-DNA
and	I-DNA
muB	I-DNA
sites	I-DNA
is	O
transactivated	O
by	O
a	O
combination	O
of	O
the	O
ETS-domain	B-protein
proteins	I-protein
PU.1	B-protein
and	O
Ets-1	B-protein
in	O
nonlymphoid	B-cell_type
cells	I-cell_type
.	O

The	O
core	O
GGAAs	O
of	O
the	O
muA	B-DNA
and	I-DNA
muB	I-DNA
sites	I-DNA
are	O
separated	O
by	O
30	O
nucleotides	O
,	O
suggesting	O
that	O
ETS	B-protein
proteins	I-protein
bind	O
to	O
these	O
sites	O
from	O
these	O
same	O
side	O
of	O
the	O
DNA	O
helix	O
.	O

We	O
tested	O
the	O
necessity	O
for	O
appropriate	O
spatial	O
alignment	O
of	O
these	O
elements	B-DNA
by	O
using	O
mutated	B-DNA
enhancers	I-DNA
with	O
altered	O
spacings	O
.	O

A	O
4-	O
or	O
10-bp	O
insertion	O
between	O
muE3	B-DNA
and	O
muB	B-DNA
inactivated	O
the	O
mu	B-DNA
enhancer	I-DNA
in	O
S194	B-cell_line
plasma	I-cell_line
cells	I-cell_line
but	O
did	O
not	O
affect	O
in	O
vitro	O
binding	O
of	O
Ets-1	O
,	O
PU.1	B-protein
,	O
or	O
the	O
muE3-binding	B-protein
protein	I-protein
TFE3	B-protein
,	O
alone	O
or	O
in	O
pairwise	O
combinations	O
.	O

Circular	O
permutation	O
and	O
phasing	O
analyses	O
demonstrated	O
that	O
PU.1	B-protein
binding	O
but	O
not	O
TFE3	B-protein
or	O
Ets-1	B-protein
bends	O
mu	B-DNA
enhancer	I-DNA
DNA	I-DNA
toward	O
the	O
major	O
groove	O
.	O

We	O
propose	O
that	O
the	O
requirement	O
for	O
precise	O
spacing	O
of	O
the	O
muA	B-DNA
and	I-DNA
muB	I-DNA
elements	I-DNA
is	O
due	O
in	O
part	O
to	O
a	O
directed	O
DNA	O
bend	O
induced	O
by	O
PU.1	B-protein
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLoGY	NULL
,	NULL
Aug.	NULL
1996	NULL
,	NULL
p.	NULL
4544-4554	NULL
0270-7306/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

16	NULL
,	NULL
No	NULL
.	NULL

8	NULL
Precise	NULL
Alignment	NULL
of	NULL
Sites	NULL
Required	NULL
for	NULL
.	NULL

Enhancer	NULL
Activation	NULL
in	NULL
B	NULL
Cells	NULL
BARBARA	NULL
S.	NULL
NIKOLAJCZYK	NULL
,	NULL
BARBARA	NULL
NELSEN	NULL
,	NULL
anp	NULL
RANJAN	NULL
SEN®*	NULL
Rosenstiel	NULL
Basic	NULL
Medical	NULL
Sciences	NULL
Research	NULL
Center	NULL
and	NULL
Department	NULL
of	NULL
Biology	NULL
,	NULL
Brandeis	NULL
University	NULL
,	NULL
Waltham	NULL
,	NULL
Massachusetts	NULL
02254-9110	NULL
Received	NULL
29	NULL
November	NULL
1995/Returned	NULL
for	NULL
modification	NULL
9	NULL
January	NULL
1996/Accepted	NULL
3	NULL
May	NULL
1996	NULL
The	NULL
lymphocyte-specific	NULL
immunoglobulin	NULL
p	NULL
heavy-chain	NULL
gene	NULL
intronic	NULL
enhancer	NULL
is	NULL
regulated	NULL
by	NULL
multiple	NULL
nuclear	NULL
factors	NULL
.	NULL

The	NULL
previously	NULL
defined	NULL
minimal	NULL
enhancer	NULL
containing	NULL
the	NULL
pA	NULL
,	NULL
E3	NULL
,	NULL
and	NULL
pB	NULL
sites	NULL
is	NULL
transac-tivated	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
ETS-domain	NULL
proteins	NULL
PU.1	NULL
and	NULL
Ets-1	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

The	NULL
core	NULL
GGAAs	NULL
of	NULL
the	NULL
pA	NULL
and	NULL
pB	NULL
sites	NULL
are	NULL
separated	NULL
by	NULL
30	NULL
nucleotides	NULL
,	NULL
suggesting	NULL
that	NULL
ETS	NULL
proteins	NULL
bind	NULL
to	NULL
these	NULL
sites	NULL
from	NULL
these	NULL
same	NULL
side	NULL
of	NULL
the	NULL
DNA	NULL
helix	NULL
.	NULL

We	NULL
tested	NULL
the	NULL
necessity	NULL
for	NULL
appropriate	NULL
spatial	NULL
alignment	NULL
of	NULL
these	NULL
elements	NULL
by	NULL
using	NULL
mutated	NULL
enhancers	NULL
with	NULL
altered	NULL
spacings	NULL
.	NULL

A	NULL
4-	NULL
or	NULL
10-bp	NULL
insertion	NULL
between	NULL
pE3	NULL
and	NULL
pB	NULL
inactivated	NULL
the	NULL
j	NULL
enhancer	NULL
in	NULL
$	NULL
194	NULL
plasma	NULL
cells	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
in	NULL
vitro	NULL
binding	NULL
of	NULL
Ets-1	NULL
,	NULL
PU.1	NULL
,	NULL
or	NULL
the	NULL
mE3-binding	NULL
protein	NULL
TFE3	NULL
,	NULL
alone	NULL
or	NULL
in	NULL
pairwise	NULL
combinations	NULL
.	NULL

Circular	NULL
permutation	NULL
and	NULL
phasing	NULL
analyses	NULL
demonstrated	NULL
that	NULL
PU.1	NULL
binding	NULL
but	NULL
not	NULL
TFE3	NULL
or	NULL
Ets-1	NULL
bends	NULL
pu	NULL
enhancer	NULL
DNA	NULL
toward	NULL
the	NULL
major	NULL
groove	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
the	NULL
requirement	NULL
for	NULL
precise	NULL
spacing	NULL
of	NULL
the	NULL
pA	NULL
and	NULL
B	NULL
elements	NULL
is	NULL
due	NULL
in	NULL
part	NULL
to	NULL
a	NULL
directed	NULL
DNA	NULL
bend	NULL
induced	NULL
by	NULL
PU.1	NULL
.	NULL

A	NULL
key	NULL
molecular	NULL
event	NULL
in	NULL
B-cell	NULL
development	NULL
is	NULL
the	NULL
activation	NULL
of	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
.	NULL

heavy-chain	NULL
(	NULL
)	NULL
gene	NULL
rearrangements	NULL
in	NULL
the	NULL
earliest	NULL
discernible	NULL
B-cell	NULL
precursor	NULL
.	NULL

Correlation	NULL
of	NULL
transcription	NULL
activation	NULL
with	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
(	NULL
1	NULL
,	NULL
5	NULL
)	NULL
implicated	NULL
the	NULL
p	NULL
enhancer	NULL
,	NULL
located	NULL
between	NULL
the	NULL
J	NULL
;	NULL
,	NULL
and	NULL
C	NULL
,	NULL
,	NULL
exons	NULL
,	NULL
as	NULL
the	NULL
probable	NULL
regulatory	NULL
target	NULL
directing	NULL
Ig	NULL
heavy-chain	NULL
gene	NULL
recombination	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
the	NULL
p	NULL
enhancer	NULL
in	NULL
recombination	NULL
and	NULL
transcriptional	NULL
activation	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
of	NULL
sterile	NULL
transcripts	NULL
that	NULL
initiated	NULL
within	NULL
the	NULL
enhancer	NULL
(	NULL
31	NULL
)	NULL
and	NULL
by	NULL
the	NULL
analysis	NULL
of	NULL
recombination	NULL
substrates	NULL
in	NULL
cell	NULL
lines	NULL
(	NULL
44	NULL
)	NULL
and	NULL
transgenic	NULL
mice	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
role	NULL
for	NULL
this	NULL
enhancer	NULL
in	NULL
regulating	NULL
accessibility	NULL
was	NULL
suggested	NULL
by	NULL
the	NULL
studies	NULL
of	NULL
Jenuwein	NULL
et	NULL
al	NULL
.	NULL

(	NULL
23	NULL
)	NULL
,	NULL
who	NULL
showed	NULL
that	NULL
a	NULL
transgenic	NULL
p	NULL
enhancer	NULL
conferred	NULL
access	NULL
of	NULL
bacterial	NULL
RNA	NULL
poly-merases	NULL
to	NULL
adjacent	NULL
DNA	NULL
.	NULL

Recently	NULL
,	NULL
genetic	NULL
disruption	NULL
of	NULL
the	NULL
p	NULL
enhancer	NULL
in	NULL
mice	NULL
(	NULL
8	NULL
,	NULL
51	NULL
)	NULL
has	NULL
directly	NULL
demonstrated	NULL
a	NULL
role	NULL
for	NULL
this	NULL
enhancer	NULL
in	NULL
Ig	NULL
heavy-chain	NULL
gene	NULL
rearrangement	NULL
.	NULL

The	NULL
p	NULL
enhancer	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
multiple	NULL
nuclear	NULL
factors	NULL
(	NULL
32	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Three	NULL
known	NULL
elements	NULL
,	NULL
pA	NULL
,	NULL
1B	NULL
,	NULL
and	NULL
octamer	NULL
,	NULL
bind	NULL
proteins	NULL
with	NULL
restricted	NULL
tissue	NULL
distribution	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
wE1	NULL
to	NULL
wE5	NULL
sites	NULL
in	NULL
the	NULL
p	NULL
enhancer	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
extracts	NULL
made	NULL
from	NULL
B	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

These	NULL
factors	NULL
,	NULL
including	NULL
the	NULL
EZA	NULL
gene	NULL
products	NULL
,	NULL
belong	NULL
to	NULL
the	NULL
basic	NULL
helix-loop-helix	NULL
(	NULL
bHLH	NULL
)	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
37	NULL
)	NULL
and	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
E5	NULL
motif	NULL
that	NULL
acts	NULL
as	NULL
a	NULL
positive	NULL
element	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
46	NULL
)	NULL
also	NULL
interacts	NULL
with	NULL
a	NULL
ubiquitous	NULL
leucine	NULL
zipper	NULL
protein	NULL
,	NULL
ZEB	NULL
,	NULL
that	NULL
has	NULL
been	NULL
proposed	NULL
as	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
the	NULL
enhancer	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Secondly	NULL
,	NULL
in	NULL
BxT	NULL
somatic	NULL
cell	NULL
hybrids	NULL
,	NULL
where	NULL
Ig	NULL
heavy-chain	NULL
expression	NULL
is	NULL
extinguished	NULL
,	NULL
one	NULL
of	NULL
the	NULL
targets	NULL
of	NULL
repression	NULL
is	NULL
the	NULL
wE4	NULL
element	NULL
of	NULL
the	NULL
p	NULL
enhancer	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
mutation	NULL
of	NULL
the	NULL
E2A	NULL
(	NULL
bHLH	NULL
)	NULL
gene	NULL
by	NULL
homol-ogous	NULL
recombination	NULL
results	NULL
in	NULL
a	NULL
developmental	NULL
block	NULL
of	NULL
B-cell	NULL
differentiation	NULL
at	NULL
a	NULL
very	NULL
early	NULL
stage	NULL
(	NULL
2	NULL
,	NULL
61	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
same	NULL
phenotype	NULL
is	NULL
obtained	NULL
by	NULL
transgenic	NULL
overexpression	NULL
of	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
617	NULL
)	NULL
736-2454	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
617	NULL
)	NULL
736-2405	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
sen	NULL
@	NULL
binah.cc.brandeis.edu	NULL
.	NULL

4544	NULL
Id-1	NULL
,	NULL
a	NULL
protein	NULL
known	NULL
to	NULL
heterodimerize	NULL
with	NULL
E2A	NULL
gene	NULL
products	NULL
and	NULL
prevent	NULL
DNA	NULL
binding	NULL
by	NULL
these	NULL
proteins	NULL
(	NULL
54	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
these	NULL
experiments	NULL
indicate	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
bHLH	NULL
gene	NULL
products	NULL
in	NULL
lymphocyte	NULL
differentiation	NULL
.	NULL

In	NULL
this	NULL
array	NULL
of	NULL
factor-binding	NULL
sites	NULL
,	NULL
mutation	NULL
of	NULL
a	NULL
single	NULL
element	NULL
typically	NULL
does	NULL
not	NULL
result	NULL
in	NULL
significant	NULL
reduction	NULL
of	NULL
enhancer	NULL
activity	NULL
in	NULL
plasma	NULL
cells	NULL
(	NULL
32	NULL
)	NULL
.	NULL

This	NULL
has	NULL
been	NULL
interpreted	NULL
to	NULL
indicate	NULL
that	NULL
there	NULL
is	NULL
substantial	NULL
redundancy	NULL
built	NULL
into	NULL
the	NULL
enhancer	NULL
.	NULL

However	NULL
,	NULL
analysis	NULL
of	NULL
multiply	NULL
mutated	NULL
enhancers	NULL
shows	NULL
that	NULL
elements	NULL
that	NULL
bind	NULL
both	NULL
the	NULL
tissue-restricted	NULL
and	NULL
ubiquitous	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
enhancer	NULL
function	NULL
.	NULL

How	NULL
these	NULL
two	NULL
types	NULL
of	NULL
proteins	NULL
collaborate	NULL
to	NULL
generate	NULL
a	NULL
functional	NULL
enhancer	NULL
is	NULL
,	NULL
at	NULL
present	NULL
,	NULL
unknown	NULL
.	NULL

To	NULL
simplify	NULL
further	NULL
analysis	NULL
of	NULL
the	NULL
p	NULL
enhancer	NULL
,	NULL
we	NULL
have	NULL
previously	NULL
identified	NULL
a	NULL
minimal	NULL
enhancer	NULL
that	NULL
contains	NULL
no	NULL
redundant	NULL
mo-tifs	NULL
.	NULL

The	NULL
minimal	NULL
enhancer	NULL
contains	NULL
the	NULL
pA	NULL
and	NULL
wB	NULL
elements	NULL
that	NULL
bind	NULL
ETS-domain	NULL
proteins	NULL
(	NULL
42	NULL
)	NULL
,	NULL
along	NULL
with	NULL
the	NULL
E3	NULL
element	NULL
that	NULL
binds	NULL
several	NULL
factors	NULL
belonging	NULL
to	NULL
the	NULL
bHLH-zip	NULL
family	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
16	NULL
,	NULL
48	NULL
,	NULL
49	NULL
)	NULL
.	NULL

The	NULL
minimal	NULL
enhancer	NULL
is	NULL
B-cell	NULL
specific	NULL
,	NULL
and	NULL
mutation	NULL
of	NULL
any	NULL
one	NULL
of	NULL
the	NULL
three	NULL
sites	NULL
significantly	NULL
diminishes	NULL
enhancer	NULL
activity	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
minimal	NULL
enhancer	NULL
is	NULL
also	NULL
a	NULL
composite	NULL
of	NULL
tissue-restricted	NULL
and	NULL
ubiquitous	NULL
protein-binding	NULL
sites	NULL
,	NULL
suggesting	NULL
that	NULL
its	NULL
analysis	NULL
will	NULL
provide	NULL
insights	NULL
into	NULL
the	NULL
mechanism	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
full	NULL
p	NULL
enhancer	NULL
.	NULL

Both	NULL
mA	NULL
and	NULL
pB	NULL
sites	NULL
contain	NULL
the	NULL
consensus	NULL
element	NULL
(	NULL
GGA	NULL
)	NULL
for	NULL
binding	NULL
members	NULL
of	NULL
the	NULL
ETS-domain	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
ETS	NULL
family	NULL
member	NULL
PU.1	NULL
,	NULL
a	NULL
hematopoietic	NULL
cell-specific	NULL
protein	NULL
,	NULL
binds	NULL
to	NULL
the	NULL
pB	NULL
site	NULL
and	NULL
activates	NULL
the	NULL
p	NULL
enhancer	NULL
weakly	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
Ets-1	NULL
,	NULL
a	NULL
more	NULL
widely	NULL
distributed	NULL
protein	NULL
,	NULL
binds	NULL
the	NULL
pA	NULL
site	NULL
but	NULL
alone	NULL
does	NULL
not	NULL
activate	NULL
the	NULL
enhancer	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
coexpression	NULL
of	NULL
Ets-1	NULL
and	NULL
PU.1	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
results	NULL
in	NULL
synergistic	NULL
activation	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
regulated	NULL
by	NULL
the	NULL
minimal	NULL
p	NULL
enhancer	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Our	NULL
current	NULL
study	NULL
addresses	NULL
the	NULL
mechanism	NULL
underlying	NULL
the	NULL
transactivation	NULL
of	NULL
the	NULL
p	NULL
enhancer	NULL
by	NULL
Ets-1	NULL
and	NULL
PU.1	NULL
.	NULL

Separation	NULL
of	NULL
the	NULL
pA	NULL
and	NULL
wB	NULL
sites	NULL
by	NULL
an	NULL
integral	NULL
number	NULL
of	NULL
helical	NULL
turns	NULL
of	NULL
DNA	NULL
suggested	NULL
that	NULL
the	NULL
A-	NULL
and	NULL
uB-binding	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
proteins	NULL
interacted	NULL
with	NULL
the	NULL
DNA	NULL
from	NULL
the	NULL
same	NULL
side	NULL
of	NULL
the	NULL
helix	NULL
.	NULL

We	NULL
tested	NULL
whether	NULL
alignment	NULL
of	NULL
the	NULL
pA	NULL
and	NULL
pB	NULL
sites	NULL
was	NULL
required	NULL
for	NULL
enhancer	NULL
activity	NULL
by	NULL
inserting	NULL
nucleotides	NULL
to	NULL
alter	NULL
the	NULL
distance	NULL
between	NULL
them	NULL
.	NULL

Although	NULL
binding	NULL
of	NULL
one	NULL
or	NULL
more	NULL
purified	NULL
proteins	NULL
to	NULL
the	NULL
enhancer	NULL
was	NULL
not	NULL
weakened	NULL
by	NULL
the	NULL
insertion	NULL
mutations	NULL
,	NULL
alteration	NULL
of	NULL
the	NULL
alignment	NULL
between	NULL
the	NULL
cis	NULL
elements	NULL
inactivated	NULL
the	NULL
.	NULL

enhancer	NULL
in	NULL
fully	NULL
differentiated	NULL
B	NULL
cells	NULL
.	NULL

Circular	NULL
permutation	NULL
and	NULL
phasing	NULL
analyses	NULL
demonstrated	NULL
that	NULL
PU.1	NULL
,	NULL
but	NULL
not	NULL
TFE3	NULL
or	NULL
Ets-1	NULL
,	NULL
bends	NULL
DNA	NULL
and	NULL
therefore	NULL
may	NULL
contribute	NULL
structurally	NULL
to	NULL
the	NULL
p	NULL
enhancer	NULL
multiprotein	NULL
complex	NULL
.	NULL

Overall	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
a	NULL
stereospecific	NULL
multiprotein	NULL
enhancer	NULL
complex	NULL
activates	NULL
the	NULL
Ig	NULL
p	NULL
heavy-chain	NULL
gene	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Expression	NULL
and	NULL
purification	NULL
of	NULL
recombinant	NULL
proteins	NULL
.	NULL

(	NULL
i	NULL
)	NULL
His.PU	NULL
.	NULL

A	NULL
1.3-kb	NULL
Pvull-EcoRI	NULL
fragment	NULL
containing	NULL
the	NULL
full-length	NULL
murine	NULL
PU.1	NULL
cDNA	NULL
was	NULL
treated	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
plus	NULL
deoxynucleoside	NULL
triphos-phates	NULL
(	NULL
dNTPs	NULL
)	NULL
and	NULL
cloned	NULL
into	NULL
Xhol-digested	NULL
,	NULL
Klenow-treated	NULL
pET14b	NULL
plasmid	NULL
(	NULL
Novagen	NULL
)	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
His.Ets	NULL
.	NULL

The	NULL
ETS	NULL
domain	NULL
of	NULL
Ets-1	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
pEV3S	NULL
subclone	NULL
(	NULL
92	NULL
)	NULL
.	NULL

The	NULL
pEV3S	NULL
subclone	NULL
contained	NULL
the	NULL
ETS	NULL
domain	NULL
of	NULL
Ets-1	NULL
amplified	NULL
by	NULL
PCR	NULL
with	NULL
the	NULL
following	NULL
primers	NULL
:	NULL
5-CCT	NULL
GGG	NULL
CCC	NULL
GGG	NULL
GCC	NULL
CTG	NULL
GCT	NULL
GGC	NULL
TAC	NULL
AC-3	NULL
'	NULL
(	NULL
5	NULL
'	NULL
primer	NULL
)	NULL
and	NULL
5	NULL
%	NULL
-CG	NULL
GAG	NULL
TCG	NULL
ACG	NULL
CTC	NULL
AGG	NULL
GGT	NULL
GTA	NULL
TCC	NULL
CAG	NULL
CAG-3	NULL
'	NULL
(	NULL
3	NULL
'	NULL
primer	NULL
)	NULL
.	NULL

Ets-1/pEV3S	NULL
was	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
Xbal	NULL
,	NULL
treated	NULL
with	NULL
Klenow	NULL
fragment	NULL
,	NULL
and	NULL
cloned	NULL
into	NULL
BamHI-digested	NULL
,	NULL
Klenow	NULL
treated	NULL
pET	NULL
For	NULL
protein	NULL
expression	NULL
,	NULL
the	NULL
plasmids	NULL
were	NULL
transformed	NULL
into	NULL
the	NULL
BL21	NULL
bacterial	NULL
strain	NULL
.	NULL

Protein	NULL
production	NULL
was	NULL
induced	NULL
with	NULL
0.4	NULL
mM	NULL
isopropyl-B-p-thiogalacto-pyranoside	NULL
(	NULL
IPTG	NULL
)	NULL
,	NULL
and	NULL
His-tagged	NULL
proteins	NULL
were	NULL
purified	NULL
without	NULL
denaturing	NULL
agents	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
protocol	NULL
(	NULL
Novagen	NULL
)	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
GST-TFE3	NULL
and	NULL
GST-TFE3S	NULL
.	NULL

Bacterial	NULL
expression	NULL
vectors	NULL
for	NULL
GST-TFE3	NULL
and	NULL
GST-TFE3S	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Kathryn	NULL
Calame	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
N.Y.	NULL
Glutathione-S-transferase	NULL
(	NULL
GST	NULL
)	NULL
fusion	NULL
proteins	NULL
were	NULL
purified	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
recombinant	NULL
protein	NULL
was	NULL
induced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
IPTG	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.4	NULL
mM	NULL
for	NULL
3	NULL
to	NULL
5	NULL
h.	NULL
After	NULL
induction	NULL
,	NULL
the	NULL
bacteria	NULL
were	NULL
pelleted	NULL
and	NULL
resuspended	NULL
in	NULL
NETN	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-Cl	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
by	NULL
sonication	NULL
(	NULL
three	NULL
pulses	NULL
for	NULL
10	NULL
s	NULL
each	NULL
)	NULL
at	NULL
0°C	NULL
.	NULL

The	NULL
insoluble	NULL
debris	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
the	NULL
fusion	NULL
protein	NULL
was	NULL
purified	NULL
from	NULL
the	NULL
supernatant	NULL
by	NULL
adsorption	NULL
to	NULL
glutathione-agarose	NULL
.	NULL

Sonicated	NULL
supernatant	NULL
from	NULL
1	NULL
liter	NULL
of	NULL
bacteria	NULL
was	NULL
agitated	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
a	NULL
50	NULL
%	NULL
slurry	NULL
of	NULL
glutathione	NULL
beads	NULL
for	NULL
1	NULL
to	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
25	NULL
to	NULL
30	NULL
ml	NULL
cold	NULL
NETN	NULL
buffer	NULL
.	NULL

Adsorbed	NULL
proteins	NULL
were	NULL
eluted	NULL
with	NULL
NETN	NULL
buffer	NULL
plus	NULL
5	NULL
mM	NULL
reduced	NULL
glutathione	NULL
.	NULL

Eluates	NULL
(	NULL
1	NULL
column	NULL
volume	NULL
)	NULL
were	NULL
collected	NULL
and	NULL
analyzed	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
the	NULL
most	NULL
highly	NULL
concentrated	NULL
fractions	NULL
were	NULL
pooled	NULL
and	NULL
dialyzed	NULL
against	NULL
buffer	NULL
D	NULL
(	NULL
20	NULL
mM	NULL
N-2-hydroxy-ethylpiperazine-N	NULL
'	NULL
-2-cthanesulfonic	NULL
acid	NULL
[	NULL
HEPES	NULL
;	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

Aliquots	NULL
were	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

EMSAs	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
probes	NULL
were	NULL
isolated	NULL
as	NULL
Pstl-BamHI	NULL
fragments	NULL
from	NULL
murine	NULL
a170	NULL
(	NULL
bp	NULL
381	NULL
to	NULL
433	NULL
in	NULL
the	NULL
system	NULL
of	NULL
Ephrussi	NULL
et	NULL
al	NULL
.	NULL

[	NULL
9	NULL
]	NULL
)	NULL
cloned	NULL
into	NULL
A56CAT	NULL
.	NULL

After	NULL
isolation	NULL
from	NULL
a	NULL
6	NULL
%	NULL
acrylamide	NULL
gel	NULL
,	NULL
fragments	NULL
were	NULL
phosphorylated	NULL
with	NULL
polynucleotide	NULL
kinase	NULL
and	NULL
[	NULL
y-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
ATP	NULL
.	NULL

EMSA	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
containing	NULL
10,000	NULL
cpm	NULL
of	NULL
probe	NULL
,	NULL
2.5	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
+	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
2.0	NULL
wl	NULL
of	NULL
10	NULL
%	NULL
lipage	NULL
buffer	NULL
(	NULL
10	NULL
%	NULL
lipage	NULL
is	NULL
100	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.51	NULL
,	NULL
0.5	NULL
M	NULL
NaCl	NULL
,	NULL
100	NULL
mM	NULL
B-mercaptocthanol	NULL
,	NULL
10	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
40	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

For	NULL
EMSA	NULL
with	NULL
two	NULL
recombinant	NULL
proteins	NULL
,	NULL
both	NULL
proteins	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
simultaneously	NULL
.	NULL

After	NULL
a	NULL
10-min	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
the	NULL
reaction	NULL
products	NULL
were	NULL
electrophoresed	NULL
through	NULL
nondenaturing	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0.5	NULL
%	NULL
Tris-borate	NULL
buffer	NULL
(	NULL
44	NULL
mM	NULL
Tris	NULL
borate	NULL
,	NULL
44	NULL
mM	NULL
boric	NULL
acid	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
visualized	NULL
on	NULL
DuPont	NULL
film	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Plasmids	NULL
.	NULL

The	NULL
+4	NULL
,	NULL
+10	NULL
,	NULL
and	NULL
downstream	NULL
+18	NULL
spacing	NULL
mutations	NULL
were	NULL
made	NULL
in	NULL
the	NULL
previously	NULL
described	NULL
M100	NULL
mutation	NULL
(	NULL
40	NULL
)	NULL
,	NULL
which	NULL
introduces	NULL
a	NULL
Seel	NULL
site	NULL
between	NULL
E3	NULL
and	NULL
wB	NULL
.	NULL

For	NULL
the	NULL
+10	NULL
mutation	NULL
,	NULL
a	NULL
Spel	NULL
linker	NULL
(	NULL
GGACTAGTCC	NULL
)	NULL
was	NULL
ligated	NULL
into	NULL
Scal-cut	NULL
M100	NULL
DNA	NULL
.	NULL

The	NULL
+4	NULL
mutation	NULL
was	NULL
generated	NULL
by	NULL
digesting	NULL
the	NULL
+10	NULL
mutation	NULL
with	NULL
Spel	NULL
followed	NULL
by	NULL
S1	NULL
nuclease	NULL
treatment	NULL
and	NULL
religation	NULL
.	NULL

For	NULL
the	NULL
+18	NULL
mutation	NULL
,	NULL
M100	NULL
was	NULL
digested	NULL
with	NULL
BemHI	NULL
and	NULL
treated	NULL
with	NULL
Klenow	NULL
fragment	NULL
to	NULL
produce	NULL
blunt	NULL
ends	NULL
and	NULL
then	NULL
the	NULL
Spel	NULL
linker	NULL
was	NULL
ligated	NULL
into	NULL
this	NULL
site	NULL
.	NULL

The	NULL
BemHI	NULL
introduced	NULL
by	NULL
site-specific	NULL
mutagenesis	NULL
of	NULL
the	NULL
core	NULL
1	NULL
(	NULL
24	NULL
)	NULL
site	NULL
lies	NULL
3	NULL
'	NULL
of	NULL
pB	NULL
.	NULL

All	NULL
spacing	NULL
mutations	NULL
were	NULL
generated	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
700-bp	NULL
Xbal-EcoRI	NULL
fragment	NULL
of	NULL
the	NULL
p.	NULL
enhancer	NULL
.	NULL

For	NULL
transfection	NULL
analyses	NULL
,	NULL
(	NULL
70	NULL
)	NULL
;	NULL
plasmids	NULL
were	NULL
generated	NULL
from	NULL
the	NULL
mutated	NULL
enhancers	NULL
by	NULL
isolating	NULL
the	NULL
AluI-AluI	NULL
fragment	NULL
encompassing	NULL
nucleotides	NULL
385	NULL
to	NULL
455	NULL
(	NULL
numbering	NULL
according	NULL
to	NULL
the	NULL
system	NULL
of	NULL
Ephrussi	NULL
et	NULL
al	NULL
.	NULL

[	NULL
9	NULL
]	NULL
)	NULL
and	NULL
cloning	NULL
into	NULL
w	NULL
ENHANCER	NULL
ACTIVATION	NULL
REQUIRES	NULL
SITE	NULL
ALIGNMENT	NULL
4545	NULL
the	NULL
vector	NULL
A56	NULL
fos	NULL
CAT	NULL
(	NULL
15	NULL
)	NULL
,	NULL
which	NULL
was	NULL
cut	NULL
with	NULL
Sell	NULL
and	NULL
treated	NULL
with	NULL
Klenow	NULL
fragment	NULL
.	NULL

For	NULL
the	NULL
£170	NULL
plasmids	NULL
,	NULL
the	NULL
Hinfl-Ddel	NULL
enhancer	NULL
fragments	NULL
(	NULL
residues	NULL
346	NULL
to	NULL
518	NULL
[	NULL
9	NULL
]	NULL
)	NULL
containing	NULL
the	NULL
mutations	NULL
were	NULL
treated	NULL
with	NULL
Klenow	NULL
fragment	NULL
and	NULL
cloned	NULL
into	NULL
pBluescript	NULL
SK+	NULL
cut	NULL
with	NULL
Hincll	NULL
.	NULL

HindIII-Xhol	NULL
fragments	NULL
isolated	NULL
from	NULL
these	NULL
clones	NULL
were	NULL
then	NULL
ligated	NULL
into	NULL
A56	NULL
fos	NULL
CAT	NULL
cut	NULL
with	NULL
HindIII	NULL
and	NULL
Sef	NULL
.	NULL

The	NULL
orientation	NULL
of	NULL
the	NULL
170	NULL
fragments	NULL
is	NULL
such	NULL
that	NULL
the	NULL
5°	NULL
HinfI	NULL
end	NULL
of	NULL
the	NULL
enhancer	NULL
is	NULL
adjacent	NULL
to	NULL
the	NULL
minimal	NULL
fos	NULL
promoter	NULL
.	NULL

All	NULL
plasmids	NULL
were	NULL
purified	NULL
with	NULL
Qiagen	NULL
100	NULL
preparative	NULL
columns	NULL
and	NULL
sequenced	NULL
to	NULL
confirm	NULL
the	NULL
presence	NULL
of	NULL
mutations	NULL
and	NULL
the	NULL
orientations	NULL
.	NULL

The	NULL
orientations	NULL
of	NULL
the	NULL
70	NULL
dimers	NULL
are	NULL
as	NULL
previously	NULL
described	NULL
by	NULL
Nelsen	NULL
et	NULL
al	NULL
.	NULL

(	NULL
42	NULL
)	NULL
.	NULL

Murine	NULL
$	NULL
194	NULL
plasma	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
mg	NULL
of	NULL
plasmid	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
17	NULL
)	NULL
and	NULL
harvested	NULL
42	NULL
to	NULL
48	NULL
hs	NULL
posttransfection	NULL
.	NULL

Protein	NULL
(	NULL
5	NULL
to	NULL
10	NULL
pg	NULL
)	NULL
was	NULL
analyzed	NULL
in	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
39	NULL
)	NULL
,	NULL
and	NULL
the	NULL
results	NULL
were	NULL
quantitated	NULL
by	NULL
phosphorimager	NULL
analysis	NULL
.	NULL

DNA-bending	NULL
analysis	NULL
.	NULL

All	NULL
bend	NULL
angles	NULL
were	NULL
estimated	NULL
from	NULL
equations	NULL
cited	NULL
by	NULL
Thompson	NULL
and	NULL
Landy	NULL
(	NULL
56	NULL
)	NULL
as	NULL
modified	NULL
by	NULL
Kerppola	NULL
and	NULL
Curran	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
center	NULL
of	NULL
the	NULL
DNA	NULL
bend	NULL
in	NULL
circular	NULL
permutation	NULL
analysis	NULL
was	NULL
determined	NULL
as	NULL
a	NULL
function	NULL
of	NULL
distance	NULL
(	NULL
in	NULL
base	NULL
pairs	NULL
)	NULL
from	NULL
the	NULL
end	NULL
of	NULL
the	NULL
probe	NULL
to	NULL
the	NULL
center	NULL
of	NULL
the	NULL
uB	NULL
GGAA	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Fisher	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
.	NULL

Identical	NULL
results	NULL
for	NULL
the	NULL
DNA	NULL
bend	NULL
center	NULL
were	NULL
obtained	NULL
relative	NULL
to	NULL
the	NULL
center	NULL
of	NULL
the	NULL
wE3	NULL
CATGTG	NULL
core-binding	NULL
site	NULL
.	NULL

For	NULL
circular	NULL
permutation	NULL
analysis	NULL
,	NULL
the	NULL
PsfI-BamHI	NULL
Klenow-treated	NULL
p.	NULL
enhancer	NULL
fragment	NULL
(	NULL
bp	NULL
381	NULL
to	NULL
433	NULL
)	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
Klenow-treated	NULL
Seil	NULL
site	NULL
of	NULL
the	NULL
pBend	NULL
vector	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Fragments	NULL
were	NULL
excised	NULL
with	NULL
M/ul	NULL
,	NULL
Spel	NULL
,	NULL
EcoRV	NULL
,	NULL
Nrul	NULL
,	NULL
or	NULL
BamHI	NULL
,	NULL
dephosphorylated	NULL
,	NULL
and	NULL
*°P	NULL
labeled	NULL
as	NULL
described	NULL
above	NULL
for	NULL
EMSA	NULL
.	NULL

Alternatively	NULL
,	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
.PU	NULL
oligonucleotide	NULL
(	NULL
GAT	NULL
CCC	NULL
TCT	NULL
GAA	NULL
AGA	NULL
GGA	NULL
ACT	NULL
TGG	NULL
)	NULL
was	NULL
cloned	NULL
into	NULL
pBend	NULL
and	NULL
circular	NULL
permutation	NULL
fragments	NULL
were	NULL
excised	NULL
with	NULL
Miul	NULL
,	NULL
Spel	NULL
,	NULL
EcoRV	NULL
,	NULL
Nrul	NULL
,	NULL
or	NULL
Rsal	NULL
.	NULL

EMSA	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
DNA	NULL
flexure	NULL
angle	NULL
was	NULL
calculated	NULL
by	NULL
using	NULL
the	NULL
equation	NULL
py	NULL
;	NULL
/p	NULL
;	NULL
=	NULL
cos	NULL
in	NULL
which	NULL
m	NULL
,	NULL
is	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
protein-DNA	NULL
complex	NULL
with	NULL
the	NULL
bend	NULL
at	NULL
the	NULL
middle	NULL
and	NULL
py	NULL
;	NULL
is	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
protein-DNA	NULL
complex	NULL
with	NULL
the	NULL
bend	NULL
at	NULL
the	NULL
end	NULL
.	NULL

u	NULL
,	NULL
,	NULL
was	NULL
determined	NULL
from	NULL
the	NULL
EcoRV	NULL
fragment	NULL
for	NULL
PU.1	NULL
or	NULL
the	NULL
Nrul	NULL
fragment	NULL
for	NULL
TFE3S/USF	NULL
.	NULL

py	NULL
was	NULL
determined	NULL
from	NULL
the	NULL
BamHI	NULL
fragment	NULL
for	NULL
all	NULL
proteins	NULL
binding	NULL
the	NULL
p.	NULL
enhancer	NULL
,	NULL
but	NULL
the	NULL
Mil	NULL
fragments	NULL
represented	NULL
py	NULL
;	NULL
for	NULL
the	NULL
SV40.PU	NULL
series	NULL
.	NULL

A	NULL
standard	NULL
curve	NULL
was	NULL
generated	NULL
by	NULL
measuring	NULL
mobilities	NULL
of	NULL
fragments	NULL
containing	NULL
two	NULL
to	NULL
seven	NULL
A	NULL
tracts	NULL
located	NULL
either	NULL
in	NULL
the	NULL
middle	NULL
(	NULL
1	NULL
,	NULL
,	NULL
)	NULL
or	NULL
at	NULL
the	NULL
end	NULL
(	NULL
j	NULL
;	NULL
)	NULL
of	NULL
the	NULL
DNA	NULL
fragment	NULL
.	NULL

The	NULL
py	NULL
,	NULL
/ps	NULL
ratio	NULL
was	NULL
plotted	NULL
as	NULL
a	NULL
function	NULL
of	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
-tract-induced	NULL
angle	NULL
to	NULL
derive	NULL
the	NULL
standard	NULL
curve	NULL
.	NULL

Calculated	NULL
values	NULL
agreed	NULL
well	NULL
with	NULL
values	NULL
obtained	NULL
from	NULL
the	NULL
standard	NULL
curve	NULL
.	NULL

A	NULL
coefficient	NULL
,	NULL
k	NULL
,	NULL
introduced	NULL
by	NULL
Kerppola	NULL
and	NULL
Curran	NULL
(	NULL
26	NULL
)	NULL
to	NULL
account	NULL
for	NULL
gel	NULL
and	NULL
fragment	NULL
size	NULL
variables	NULL
,	NULL
was	NULL
also	NULL
calculated	NULL
from	NULL
these	NULL
standard	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
-tract	NULL
fragments	NULL
by	NULL
using	NULL
the	NULL
equation	NULL
py/	NULL
;	NULL
=	NULL
cos	NULL
(	NULL
k	NULL
«	NULL
/2	NULL
)	NULL
.	NULL

For	NULL
this	NULL
calculation	NULL
,	NULL
it	NULL
was	NULL
assumed	NULL
that	NULL
each	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tract	NULL
bent	NULL
the	NULL
DNA	NULL
to	NULL
an	NULL
18°	NULL
angle	NULL
(	NULL
56	NULL
)	NULL
such	NULL
that	NULL
for	NULL
the	NULL
fragment	NULL
with	NULL
two	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tracts	NULL
,	NULL
a	NULL
=	NULL
36°	NULL
,	NULL
etc	NULL
.	NULL

The	NULL
coefficient	NULL
k	NULL
(	NULL
0.67	NULL
)	NULL
was	NULL
used	NULL
for	NULL
quantitation	NULL
of	NULL
phasing	NULL
analyses	NULL
.	NULL

Probes	NULL
for	NULL
phasing	NULL
analysis	NULL
contained	NULL
the	NULL
Pvell-BamHI	NULL
(	NULL
bp	NULL
385	NULL
to	NULL
433	NULL
)	NULL
enhancer	NULL
fragment	NULL
,	NULL
which	NULL
was	NULL
treated	NULL
with	NULL
Klenow	NULL
or	NULL
mung	NULL
bean	NULL
nuclease	NULL
prior	NULL
to	NULL
ligation	NULL
with	NULL
the	NULL
vector	NULL
.	NULL

Vectors	NULL
were	NULL
derived	NULL
from	NULL
pTK401-26	NULL
or	NULL
pTK401-28	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
after	NULL
excision	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
with	NULL
Xbel	NULL
and	NULL
Sell	NULL
and	NULL
subsequent	NULL
treatment	NULL
with	NULL
Klenow	NULL
fragment	NULL
and	NULL
deoxynucleotides	NULL
.	NULL

Various	NULL
combinations	NULL
of	NULL
fragments	NULL
and	NULL
vectors	NULL
resulted	NULL
in	NULL
constructs	NULL
containing	NULL
29	NULL
,	NULL
34	NULL
,	NULL
36	NULL
,	NULL
39	NULL
,	NULL
or	NULL
41	NULL
bp	NULL
between	NULL
the	NULL
centers	NULL
of	NULL
the	NULL
mB	NULL
site	NULL
(	NULL
between	NULL
the	NULL
C	NULL
and	NULL
A	NULL
of	NULL
the	NULL
sequence	NULL
5-TTCCCCAAA-3	NULL
'	NULL
)	NULL
and	NULL
the	NULL
minor-groove	NULL
bending	NULL
A	NULL
tracts	NULL
.	NULL

This	NULL
distance	NULL
was	NULL
designated	NULL
the	NULL
spacer	NULL
;	NULL
spacer	NULL
length	NULL
differed	NULL
depending	NULL
on	NULL
the	NULL
protein-binding	NULL
site	NULL
,	NULL
with	NULL
mB	NULL
spacers	NULL
being	NULL
the	NULL
shortest	NULL
and	NULL
mA	NULL
spacers	NULL
being	NULL
the	NULL
longest	NULL
.	NULL

Phasing	NULL
analysis	NULL
was	NULL
quantitated	NULL
from	NULL
the	NULL
best	NULL
cosine	NULL
curve	NULL
fit	NULL
to	NULL
the	NULL
EMSA	NULL
phasing	NULL
data	NULL
.	NULL

EMSA	NULL
data	NULL
were	NULL
first	NULL
expressed	NULL
as	NULL
complex	NULL
mobility/mean	NULL
mobility	NULL
for	NULL
all	NULL
five	NULL
phasing	NULL
complexes	NULL
and	NULL
then	NULL
plotted	NULL
as	NULL
a	NULL
function	NULL
of	NULL
the	NULL
number	NULL
of	NULL
base	NULL
pairs	NULL
between	NULL
the	NULL
middle	NULL
of	NULL
the	NULL
protein-binding	NULL
site	NULL
and	NULL
the	NULL
middle	NULL
of	NULL
the	NULL
3	NULL
'	NULL
phased	NULL
A	NULL
tracts	NULL
by	NULL
using	NULL
KaleidaGraph	NULL
.	NULL

The	NULL
fit	NULL
of	NULL
the	NULL
cosine	NULL
curve	NULL
to	NULL
the	NULL
datum	NULL
points	NULL
was	NULL
statistically	NULL
significant	NULL
(	NULL
chi-square	NULL
values	NULL
,	NULL
<	NULL
0.005	NULL
;	NULL
R	NULL
values	NULL
,	NULL
>	NULL
0.98	NULL
)	NULL
.	NULL

The	NULL
horizontal	NULL
phase	NULL
shift	NULL
was	NULL
subtracted	NULL
from	NULL
the	NULL
spacer	NULL
length	NULL
to	NULL
center	NULL
the	NULL
function	NULL
near	NULL
the	NULL
y	NULL
axis	NULL
.	NULL

This	NULL
adjustment	NULL
allowed	NULL
determination	NULL
of	NULL
bend	NULL
direction	NULL
as	NULL
described	NULL
in	NULL
Results	NULL
.	NULL

The	NULL
amplitude	NULL
of	NULL
the	NULL
cosine	NULL
function	NULL
is	NULL
equal	NULL
to	NULL
the	NULL
phasing	NULL
amplitude	NULL
,	NULL
Apy	NULL
.	NULL

Apy	NULL
used	NULL
in	NULL
conjunction	NULL
with	NULL
coefficient	NULL
k	NULL
and	NULL
a	NULL
standard	NULL
bend	NULL
angle	NULL
(	NULL
«	NULL
,	NULL
,4	NULL
)	NULL
of	NULL
54°	NULL
(	NULL
for	NULL
the	NULL
three	NULL
phased	NULL
A	NULL
tracts	NULL
in	NULL
the	NULL
fragment	NULL
)	NULL
defines	NULL
the	NULL
circular	NULL
permutation	NULL
angle	NULL
(	NULL
ac	NULL
,	NULL
)	NULL
from	NULL
the	NULL
equation	NULL
(	NULL
Ara/2	NULL
)	NULL
tan	NULL
(	NULL
king/2	NULL
)	NULL
=	NULL
taJIOiH—asm/Z	NULL
)	NULL
RESULTS	NULL
Our	NULL
previous	NULL
analysis	NULL
suggested	NULL
that	NULL
the	NULL
pA	NULL
and	NULL
pB	NULL
sites	NULL
are	NULL
essential	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
murine	NULL
p.	NULL
heavy-chain	NULL
gene	NULL
enhancer	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Examination	NULL
of	NULL
the	NULL
corresponding	NULL
regions	NULL
of	NULL
the	NULL
Ig	NULL
heavy-chain	NULL
locus	NULL
from	NULL
other	NULL
mammalian	NULL
species	NULL
showed	NULL
4546	NULL
NIKOLAJCZYK	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
E3	NULL
B	NULL
W	NULL
I2	NULL
b	NULL
Mouse	NULL
_	NULL
CTGGCAGGAAGCAGGTCATGTGGCAAGGCTATT	NULL
lﬁGGGAAGGGAA	NULL
Rat	NULL
-	NULL
ttt	NULL
t	NULL
tmm	NULL
n	NULL
tnt	NULL
nt	NULL
ntt	NULL
ttn	NULL
nt	NULL
n	NULL
n	NULL
nr	NULL
t	NULL
n	NULL
non	NULL
n	NULL
n	NULL
t	NULL
t=	NULL
[	NULL
o	NULL
s	NULL
<	NULL
e	NULL
>	NULL
+	NULL
>	NULL
<	NULL
e	NULL
>	NULL
Human	NULL
=	NULL
<	NULL
==	NULL
t	NULL
nnn	NULL
concn	NULL
CCGC	NULL
AG	NULL
-T	NULL
--	NULL
~-	NULL
>	NULL
--	NULL
TA	NULL
~	NULL
>	NULL
CA	NULL
~~	NULL
Rabbit	NULL
I	NULL
T	NULL
~~	NULL
-GCACT	NULL
-AG	NULL
--	NULL
T	NULL
--	NULL
-	NULL
>	NULL
TA	NULL
>	NULL
>	NULL
>	NULL
>	NULL
CC	NULL
--	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Comparison	NULL
of	NULL
mammalian	NULL
p.	NULL
enhancer	NULL
sequences	NULL
.	NULL

The	NULL
human	NULL
,	NULL
rat	NULL
,	NULL
and	NULL
rabbit	NULL
enhancer	NULL
sequences	NULL
were	NULL
obtained	NULL
from	NULL
Hayday	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
,	NULL
Brugge-mann	NULL
et	NULL
al	NULL
.	NULL

(	NULL
6	NULL
)	NULL
,	NULL
and	NULL
Mage	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

mA	NULL
,	NULL
E3	NULL
,	NULL
and	NULL
pB	NULL
sites	NULL
of	NULL
the	NULL
murine	NULL
enhancer	NULL
are	NULL
indicated	NULL
by	NULL
brackets	NULL
above	NULL
the	NULL
sequence	NULL
.	NULL

Residues	NULL
of	NULL
the	NULL
rat	NULL
,	NULL
human	NULL
,	NULL
and	NULL
rabbit	NULL
sequences	NULL
that	NULL
are	NULL
identical	NULL
to	NULL
the	NULL
murine	NULL
sequence	NULL
are	NULL
indicated	NULL
by	NULL
dashes	NULL
,	NULL
and	NULL
sequence	NULL
differences	NULL
shown	NULL
as	NULL
the	NULL
altered	NULL
base	NULL
.	NULL

Residues	NULL
that	NULL
are	NULL
common	NULL
to	NULL
all	NULL
sequences	NULL
are	NULL
shown	NULL
in	NULL
boldface	NULL
type	NULL
in	NULL
the	NULL
murine	NULL
sequence	NULL
.	NULL

that	NULL
both	NULL
uA	NULL
and	NULL
pB	NULL
sites	NULL
were	NULL
highly	NULL
conserved	NULL
(	NULL
10-of-10-nucleotide	NULL
identity	NULL
at	NULL
uA	NULL
and	NULL
7-of-9-nucleotide	NULL
identity	NULL
at	NULL
wB	NULL
[	NULL
Fig	NULL
.	NULL

1	NULL
]	NULL
)	NULL
.	NULL

The	NULL
nonconserved	NULL
nucleotides	NULL
in	NULL
pB	NULL
are	NULL
not	NULL
critical	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
enhancer	NULL
,	NULL
as	NULL
previously	NULL
demonstrated	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
pA	NULL
or	NULL
wB	NULL
elements	NULL
abolishes	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
minimal	NULL
enhancer	NULL
,	NULL
but	NULL
residual	NULL
activity	NULL
of	NULL
the	NULL
uE3	NULL
site	NULL
mutation	NULL
suggests	NULL
that	NULL
this	NULL
site	NULL
contributes	NULL
to	NULL
enhancer	NULL
activation	NULL
quantitatively	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
spacing	NULL
between	NULL
the	NULL
pA	NULL
and	NULL
mB	NULL
motifs	NULL
is	NULL
evolutionarily	NULL
conserved	NULL
;	NULL
however	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
wE3	NULL
site	NULL
defined	NULL
in	NULL
the	NULL
murine	NULL
enhancer	NULL
was	NULL
absent	NULL
in	NULL
the	NULL
human	NULL
and	NULL
rabbit	NULL
enhancers	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Preservation	NULL
of	NULL
spacing	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
recognizable	NULL
E	NULL
box	NULL
suggested	NULL
that	NULL
correct	NULL
spatial	NULL
orientation	NULL
of	NULL
these	NULL
two	NULL
sites	NULL
was	NULL
critical	NULL
for	NULL
enhancer	NULL
function	NULL
.	NULL

Effect	NULL
of	NULL
insertion	NULL
mutations	NULL
on	NULL
p.	NULL
enhancer-protein	NULL
binding	NULL
.	NULL

To	NULL
test	NULL
the	NULL
hypothesis	NULL
that	NULL
the	NULL
organization	NULL
of	NULL
the	NULL
mA	NULL
and	NULL
pB	NULL
sites	NULL
and	NULL
their	NULL
cognate	NULL
transcriptional	NULL
activators	NULL
was	NULL
critical	NULL
for	NULL
enhancer	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
constructed	NULL
mutated	NULL
p	NULL
enhancers	NULL
with	NULL
either	NULL
4	NULL
or	NULL
10	NULL
bp	NULL
inserted	NULL
between	NULL
the	NULL
E3	NULL
and	NULL
wB	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
and	NULL
tested	NULL
these	NULL
mutations	NULL
in	NULL
DNA-binding	NULL
and	NULL
functional	NULL
assays	NULL
.	NULL

To	NULL
facilitate	NULL
DNA	NULL
manipulations	NULL
,	NULL
insertions	NULL
were	NULL
made	NULL
in	NULL
the	NULL
M100	NULL
.	NULL

enhancer	NULL
mutation	NULL
,	NULL
in	NULL
which	NULL
the	NULL
AGG	NULL
between	NULL
E3	NULL
and	NULL
wB	NULL
is	NULL
changed	NULL
to	NULL
GTA	NULL
to	NULL
form	NULL
a	NULL
Scal	NULL
restriction	NULL
endonuclease	NULL
site	NULL
.	NULL

The	NULL
M100	NULL
mutation	NULL
does	NULL
not	NULL
affect	NULL
u	NULL
enhancer	NULL
activation	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
40	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
changes	NULL
do	NULL
not	NULL
alter	NULL
functionally	NULL
important	NULL
sequences	NULL
.	NULL

Insertion	NULL
of	NULL
4	NULL
or	NULL
10	NULL
bp	NULL
rotates	NULL
the	NULL
wB	NULL
site	NULL
approximately	NULL
145°	NULL
or	NULL
350°	NULL
,	NULL
respectively	NULL
,	NULL
relative	NULL
to	NULL
the	NULL
mA	NULL
or	NULL
E3	NULL
sites	NULL
,	NULL
assuming	NULL
a	NULL
DNA	NULL
helical	NULL
periodicity	NULL
of	NULL
10.5	NULL
bp	NULL
.	NULL

To	NULL
eliminate	NULL
the	NULL
possibility	NULL
that	NULL
insertion	NULL
of	NULL
nucleotides	NULL
between	NULL
E3	NULL
and	NULL
wB	NULL
interferes	NULL
with	NULL
known	NULL
protein-p	NULL
enhancer	NULL
interactions	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
binding	NULL
of	NULL
recombinant	NULL
Ets-1	NULL
,	NULL
PU.1	NULL
,	NULL
or	NULL
the	NULL
prototypic	NULL
bHLH-zip	NULL
protein	NULL
,	NULL
TFE3	NULL
,	NULL
to	NULL
the	NULL
mutant	NULL
enhancer	NULL
sequences	NULL
by	NULL
EMSA	NULL
.	NULL

Full-length	NULL
Ets-1	NULL
contains	NULL
two	NULL
inhibitory	NULL
domains	NULL
,	NULL
positioned	NULL
immediately	NULL
5	NULL
'	NULL
or	NULL
3	NULL
'	NULL
to	NULL
the	NULL
ETS	NULL
domain	NULL
,	NULL
that	NULL
interfere	NULL
with	NULL
DNA-binding	NULL
activity	NULL
(	NULL
18	NULL
,	NULL
33	NULL
,	NULL
43	NULL
,	NULL
58	NULL
)	NULL
;	NULL
therefore	NULL
,	NULL
the	NULL
DNA-binding	NULL
ETS	NULL
domain	NULL
of	NULL
Ets-1	NULL
[	NULL
amino	NULL
acids	NULL
325	NULL
to	NULL
426	NULL
;	NULL
referred	NULL
to	NULL
as	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
]	NULL
was	NULL
used	NULL
in	NULL
these	NULL
assays	NULL
in	NULL
lieu	NULL
of	NULL
the	NULL
full-length	NULL
protein	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
were	NULL
added	NULL
to	NULL
DNA	NULL
probes	NULL
derived	NULL
from	NULL
the	NULL
M100	NULL
,	NULL
+4	NULL
,	NULL
or	NULL
+10	NULL
mutated	NULL
.	NULL

enhancers	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

No	NULL
difference	NULL
in	NULL
complex	NULL
formation	NULL
(	NULL
E	NULL
)	NULL
was	NULL
seen	NULL
with	NULL
these	NULL
three	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
M100	NULL
[	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
]	NULL
,	NULL
+4	NULL
[	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
]	NULL
,	NULL
and	NULL
+10	NULL
[	NULL
lanes	NULL
9	NULL
to	NULL
12	NULL
]	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
addition	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
TFE3	NULL
to	NULL
M100	NULL
or	NULL
the	NULL
insertion	NULL
mutations	NULL
resulted	NULL
in	NULL
similar	NULL
patterns	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
with	NULL
any	NULL
of	NULL
the	NULL
three	NULL
fragments	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
;	NULL
compare	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
with	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
and	NULL
lanes	NULL
9	NULL
to	NULL
12	NULL
)	NULL
.	NULL

Mobility	NULL
shift	NULL
assays	NULL
of	NULL
PU.1	NULL
with	NULL
p	NULL
enhancer	NULL
DNA	NULL
resulted	NULL
in	NULL
a	NULL
more	NULL
complex	NULL
pattern	NULL
.	NULL

At	NULL
low	NULL
protein	NULL
concentrations	NULL
,	NULL
PU.1	NULL
formed	NULL
a	NULL
single	NULL
major	NULL
nucleoprotein	NULL
complex	NULL
with	NULL
the	NULL
M100	NULL
probe	NULL
(	NULL
P	NULL
;	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
whereas	NULL
additional	NULL
,	NULL
more	NULL
slowly	NULL
migrating	NULL
complexes	NULL
appeared	NULL
at	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

higher	NULL
protein	NULL
concentrations	NULL
(	NULL
ZP	NULL
;	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
.	NULL

The	NULL
major	NULL
complex	NULL
represents	NULL
PU.1	NULL
bound	NULL
to	NULL
the	NULL
wB	NULL
site	NULL
,	NULL
as	NULL
confirmed	NULL
by	NULL
its	NULL
absence	NULL
when	NULL
a	NULL
uB	NULL
-	NULL
probe	NULL
was	NULL
used	NULL
in	NULL
these	NULL
assays	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
more	NULL
slowly	NULL
migrating	NULL
complex	NULL
probably	NULL
represents	NULL
occupancy	NULL
of	NULL
both	NULL
mA	NULL
and	NULL
pB	NULL
sites	NULL
by	NULL
PU.1	NULL
.	NULL

The	NULL
proposed	NULL
composition	NULL
of	NULL
the	NULL
second	NULL
complex	NULL
(	NULL
ZP	NULL
)	NULL
was	NULL
confirmed	NULL
by	NULL
EMSA	NULL
results	NULL
with	NULL
a	NULL
pA	NULL
mutated	NULL
enhancer	NULL
fragment	NULL
(	NULL
uA~	NULL
)	NULL
,	NULL
which	NULL
formed	NULL
only	NULL
the	NULL
complex	NULL
even	NULL
at	NULL
high	NULL
PU.1	NULL
concentrations	NULL
(	NULL
lanes	NULL
13	NULL
to	NULL
16	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
confirmed	NULL
that	NULL
PU.1	NULL
was	NULL
bound	NULL
to	NULL
both	NULL
mB	NULL
and	NULL
pA	NULL
sites	NULL
at	NULL
high	NULL
protein	NULL
concentrations	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
the	NULL
main	NULL
recognition	NULL
of	NULL
the	NULL
p.	NULL
enhancer	NULL
by	NULL
PU.1	NULL
occurs	NULL
via	NULL
the	NULL
mB	NULL
element	NULL
,	NULL
and	NULL
pB	NULL
binding	NULL
is	NULL
followed	NULL
by	NULL
recruitment	NULL
of	NULL
another	NULL
molecule	NULL
of	NULL
PU.1	NULL
to	NULL
the	NULL
mA	NULL
site	NULL
.	NULL

A	NULL
similar	NULL
pattern	NULL
of	NULL
PU.1	NULL
binding	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
+4	NULL
and	NULL
+10	NULL
nucleotide	NULL
insertion	NULL
mutation	NULL
enhancers	NULL
in	NULL
both	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
12	NULL
)	NULL
and	NULL
DNase	NULL
I	NULL
footprint	NULL
analyses	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
spacing	NULL
mutations	NULL
do	NULL
not	NULL
affect	NULL
the	NULL
binding	NULL
of	NULL
Ets-1	NULL
,	NULL
TFE3	NULL
,	NULL
or	NULL
PU.1	NULL
to	NULL
p	NULL
enhancer	NULL
DNA	NULL
.	NULL

Effect	NULL
of	NULL
insertion	NULL
mutations	NULL
on	NULL
(	NULL
p70	NULL
)	NULL
;	NULL
and	NULL
1.170	NULL
enhancer	NULL
activation	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
insertion	NULL
mutations	NULL
on	NULL
p	NULL
enhancer	NULL
function	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
mutants	NULL
for	NULL
activity	NULL
in	NULL
$	NULL
194	NULL
plasma	NULL
cells	NULL
by	NULL
transient-transfection	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

As	NULL
noted	NULL
previously	NULL
(	NULL
42	NULL
)	NULL
,	NULL
the	NULL
minimal	NULL
enhancer	NULL
,	NULL
70	NULL
,	NULL
was	NULL
analyzed	NULL
as	NULL
a	NULL
dimer	NULL
to	NULL
amplify	NULL
small	NULL
differences	NULL
.	NULL

The	NULL
M100	NULL
(	NULL
70	NULL
)	NULL
,	NULL
-containing	NULL
reporter	NULL
plasmid	NULL
was	NULL
as	NULL
active	NULL
as	NULL
the	NULL
wild-type	NULL
(	NULL
70	NULL
)	NULL
;	NULL
reporter	NULL
in	NULL
$	NULL
194	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Insertion	NULL
of	NULL
4	NULL
or	NULL
10	NULL
nucleotides	NULL
between	NULL
the	NULL
wE3	NULL
and	NULL
pB	NULL
sites	NULL
dramatically	NULL
decreased	NULL
the	NULL
activity	NULL
of	NULL
M100	NULL
(	NULL
70	NULL
)	NULL
,	NULL
derivatives	NULL
(	NULL
la-beled	NULL
M100	NULL
[	NULL
+4	NULL
]	NULL
and	NULL
M100	NULL
[	NULL
+10	NULL
]	NULL
)	NULL
to	NULL
13	NULL
or	NULL
14	NULL
%	NULL
of	NULL
M100	NULL
activation	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
observed	NULL
results	NULL
were	NULL
due	NULL
to	NULL
alteration	NULL
of	NULL
the	NULL
spacing	NULL
between	NULL
the	NULL
two	NULL
170	NULL
fragments	NULL
,	NULL
we	NULL
analyzed	NULL
a	NULL
minimal	NULL
enhancer	NULL
that	NULL
contained	NULL
18	NULL
nucleotides	NULL
introduced	NULL
3	NULL
'	NULL
of	NULL
the	NULL
wB	NULL
site	NULL
(	NULL
M100	NULL
[	NULL
+18	NULL
]	NULL
)	NULL
.	NULL

This	NULL
enhancer	NULL
was	NULL
significantly	NULL
more	NULL
active	NULL
than	NULL
either	NULL
the	NULL
+4	NULL
or	NULL
+10	NULL
enhancers	NULL
,	NULL
supporting	NULL
the	NULL
view	NULL
that	NULL
alteration	NULL
of	NULL
spacing	NULL
between	NULL
70	NULL
monomers	NULL
or	NULL
between	NULL
the	NULL
enhancer	NULL
and	NULL
promoter	NULL
was	NULL
not	NULL
detrimental	NULL
to	NULL
enhancer	NULL
activity	NULL
.	NULL

Because	NULL
the	NULL
minimal	NULL
enhancer	NULL
is	NULL
critically	NULL
dependent	NULL
on	NULL
the	NULL
integrity	NULL
of	NULL
all	NULL
three	NULL
motifs	NULL
,	NULL
the	NULL
M100	NULL
(	NULL
70	NULL
)	NULL
,	NULL
dimer	NULL
experiments	NULL
did	NULL
not	NULL
distinguish	NULL
whether	NULL
the	NULL
observed	NULL
effects	NULL
were	NULL
due	NULL
to	NULL
disruption	NULL
of	NULL
wA/pB-binding	NULL
protein	NULL
interactions	NULL
or	NULL
to	NULL
disruption	NULL
of	NULL
E3/uB-binding	NULL
protein	NULL
interactions	NULL
.	NULL

In	NULL
a	NULL
larger	NULL
enhancer	NULL
fragment	NULL
,	NULL
such	NULL
as	NULL
the	NULL
p170	NULL
which	NULL
contains	NULL
E1	NULL
,	NULL
E2	NULL
,	NULL
E3	NULL
,	NULL
and	NULL
E5	NULL
motifs	NULL
,	NULL
enhancer	NULL
activity	NULL
is	NULL
much	NULL
less	NULL
dependent	NULL
on	NULL
the	NULL
E3	NULL
element	NULL
.	NULL

However	NULL
,	NULL
mutation	NULL
of	NULL
either	NULL
pA	NULL
or	NULL
wB	NULL
elements	NULL
in	NULL
this	NULL
context	NULL
abolishes	NULL
enhancer	NULL
function	NULL
(	NULL
42	NULL
)	NULL
.	NULL

We	NULL
reasoned	NULL
that	NULL
if	NULL
the	NULL
spacing	NULL
mutations	NULL
affected	NULL
only	NULL
wE3/uB-binding	NULL
protein	NULL
interactions	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
these	NULL
mutations	NULL
in	NULL
the	NULL
context	NULL
of	NULL
170	NULL
should	NULL
be	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
a	NULL
wE3~	NULL
mu-tation	NULL
.	NULL

Alternatively	NULL
,	NULL
if	NULL
wA/pB	NULL
interactions	NULL
were	NULL
affected	NULL
,	NULL
the	NULL
spacing	NULL
mutant	NULL
activity	NULL
should	NULL
resemble	NULL
the	NULL
activity	NULL
of	NULL
uA	NULL
or	NULL
B-	NULL
enhancers	NULL
.	NULL

We	NULL
tested	NULL
the	NULL
effects	NULL
of	NULL
insertions	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
170	NULL
enhancer	NULL
by	NULL
transient	NULL
transfection	NULL
of	NULL
$	NULL
194	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
4	NULL
bp	NULL
between	NULL
uE3	NULL
and	NULL
wB	NULL
decreased	NULL
enhancer	NULL
activity	NULL
by	NULL
75	NULL
%	NULL
,	NULL
and	NULL
insertion	NULL
of	NULL
10	NULL
bp	NULL
resulted	NULL
in	NULL
a	NULL
90	NULL
%	NULL
reduction	NULL
in	NULL
transcriptional	NULL
activation	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
spacing	NULL
mutants	NULL
was	NULL
therefore	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
the	NULL
wA~	NULL
and	NULL
B-	NULL
mutant	NULL
170	NULL
enhancers	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
uE3	NULL
mutation	NULL
did	NULL
not	NULL
reduce	NULL
p170-activated	NULL
CAT	NULL
expression	NULL
significantly	NULL
.	NULL

Because	NULL
the	NULL
spacing	NULL
mutations	NULL
were	NULL
functionally	NULL
similar	NULL
to	NULL
the	NULL
pA~	NULL
or	NULL
B-	NULL
mutations	NULL
and	NULL
unlike	NULL
the	NULL
wE3~	NULL
mutation	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
the	NULL
observed	NULL
effects	NULL
are	NULL
due	NULL
to	NULL
disruption	NULL
of	NULL
appropriate	NULL
spacing	NULL
between	NULL
the	NULL
uA	NULL
and	NULL
B	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
w	NULL
ENHANCER	NULL
ACTIVATION	NULL
REQUIRES	NULL
SITE	NULL
ALIGNMENT	NULL
4547	NULL
(	NULL
ﬁ	NULL
A	NULL
A	NULL
as	NULL
o	NULL
ap	NULL
[	NULL
HEL	NULL
y-	NULL
_	NULL
m1oo	NULL
m100	NULL
Bam	NULL
H1	NULL
4	NULL
wroope	NULL
)	NULL
M100	NULL
Bam	NULL
H1	NULL
+10	NULL
-	NULL
hay	NULL
map	NULL
CEL	NULL
y	NULL
w100re10	NULL
]	NULL
Bam	NULL
H1	NULL
£s	NULL
+18/+25	NULL
pl	NULL
m	NULL
m	NULL
``	NULL
``	NULL
~	NULL
100	NULL
Bam	NULL
[	NULL
18/25	NULL
]	NULL
M100	NULL
Bam	NULL
H1	NULL
CTFEaééé	NULL
U	NULL
M	NULL
H	NULL
Wiha	NULL
attadiad	NULL
.	NULL

Auta	NULL
1	NULL
2	NULL
8	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
M100	NULL
+4	NULL
+10	NULL
8	NULL
ersigist	NULL
)	NULL
~	NULL
]	NULL
_-	NULL
~	NULL
]	NULL
_	NULL
--	NULL
]	NULL
1	NULL
2	NULL
8	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
M1000	NULL
+4	NULL
+10	NULL
P	NULL
PUA	NULL
/|/|/|/f	NULL
2p	NULL
-	NULL
»	NULL
dou	NULL
b-	NULL
»	NULL
luk	NULL
koa	NULL
>	NULL
_	NULL
»	NULL
matase	NULL
a	NULL
,	NULL
,	NULL
,	NULL
)	NULL
Oita	NULL
w..	NULL
intimin	NULL
Ee	NULL
t	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
1516	NULL
M100	NULL
+4	NULL
+10	NULL
LA	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Binding	NULL
analysis	NULL
of	NULL
mutant	NULL
enhancers	NULL
that	NULL
alter	NULL
the	NULL
distance	NULL
between	NULL
mB	NULL
and	NULL
the	NULL
5	NULL
'	NULL
pA	NULL
or	NULL
E3	NULL
elements	NULL
.	NULL

(	NULL
A	NULL
)	NULL
w	NULL
enhancer	NULL
spacing	NULL
mutants	NULL
were	NULL
made	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
functionally	NULL
active	NULL
M100	NULL
mutation	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
mA	NULL
and	NULL
B	NULL
sites	NULL
are	NULL
shown	NULL
as	NULL
single-headed	NULL
arrows	NULL
,	NULL
and	NULL
the	NULL
intervening	NULL
E3	NULL
element	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
double-headed	NULL
arrow	NULL
to	NULL
indicate	NULL
its	NULL
partially	NULL
palindromic	NULL
nature	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
Spel	NULL
linkers	NULL
were	NULL
also	NULL
used	NULL
to	NULL
introduce	NULL
the	NULL
same	NULL
nucleotides	NULL
3	NULL
'	NULL
of	NULL
the	NULL
uA/pE3/uB	NULL
functional	NULL
region	NULL
at	NULL
a	NULL
unique	NULL
BamHI	NULL
site	NULL
engineered	NULL
into	NULL
the	NULL
first	NULL
core	NULL
homology	NULL
.	NULL

70	NULL
constructs	NULL
contained	NULL
a	NULL
single	NULL
linker	NULL
(	NULL
18	NULL
additional	NULL
nucleotides	NULL
)	NULL
at	NULL
the	NULL
BamHI	NULL
site	NULL
(	NULL
M100	NULL
Bam|	NULL
[	NULL
+18	NULL
]	NULL
)	NULL
,	NULL
whereas	NULL
1170	NULL
constructs	NULL
contained	NULL
two	NULL
linkers	NULL
and	NULL
(	NULL
25	NULL
additional	NULL
nucleotides	NULL
;	NULL
M100	NULL
Bam	NULL
{	NULL
[	NULL
+25	NULL
]	NULL
)	NULL
at	NULL
this	NULL
site	NULL
.	NULL

Four	NULL
(	NULL
GGCC	NULL
)	NULL
or	NULL
10	NULL
(	NULL
GGACTAGTCC	NULL
)	NULL
nucleotides	NULL
were	NULL
inserted	NULL
between	NULL
E3	NULL
and	NULL
B	NULL
as	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
to	NULL
D	NULL
)	NULL
EMSA	NULL
analysis	NULL
of	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
spacing	NULL
mutant	NULL
enhancers	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
ETS-domain	NULL
proteins	NULL
or	NULL
TFE3	NULL
were	NULL
incubated	NULL
with	NULL
probes	NULL
derived	NULL
from	NULL
M100	NULL
or	NULL
mutant	NULL
enhancers	NULL
as	NULL
indicated	NULL
,	NULL
followed	NULL
by	NULL
nondenaturing	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Proteins	NULL
used	NULL
were	NULL
the	NULL
ETS	NULL
domain	NULL
of	NULL
Ets-1	NULL
,	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
(	NULL
B	NULL
)	NULL
,	NULL
the	NULL
protein	NULL
TFE3	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
PU.1	NULL
(	NULL
D	NULL
)	NULL
.	NULL

The	NULL
proposed	NULL
single-	NULL
and	NULL
double-occupancy	NULL
PU.1	NULL
complexes	NULL
are	NULL
indicated	NULL
as	NULL
P	NULL
and	NULL
2P	NULL
,	NULL
respectively	NULL
.	NULL

A~	NULL
refers	NULL
to	NULL
a	NULL
probe	NULL
containing	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
A	NULL
element	NULL
.	NULL

elements	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
p.	NULL
enhancer	NULL
activity	NULL
depends	NULL
upon	NULL
strict	NULL
alignment	NULL
of	NULL
the	NULL
mA	NULL
and	NULL
wB	NULL
elements	NULL
.	NULL

Binding	NULL
of	NULL
multiple	NULL
proteins	NULL
to	NULL
the	NULL
p.	NULL
enhancer	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
insertion	NULL
mutations	NULL
.	NULL

The	NULL
EMSA	NULL
analyses	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
indicated	NULL
that	NULL
binding	NULL
of	NULL
individual	NULL
enhancer	NULL
proteins	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
spacing	NULL
alterations	NULL
.	NULL

One	NULL
mechanism	NULL
by	NULL
which	NULL
insertion	NULL
mutations	NULL
may	NULL
decrease	NULL
p	NULL
enhancer	NULL
activation	NULL
is	NULL
by	NULL
affecting	NULL
the	NULL
formation	NULL
of	NULL
an	NULL
appropriate	NULL
multiprotein	NULL
complex	NULL
on	NULL
the	NULL
DNA	NULL
.	NULL

To	NULL
examine	NULL
potential	NULL
perturbations	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
such	NULL
a	NULL
complex	NULL
,	NULL
we	NULL
tested	NULL
simultaneous	NULL
binding	NULL
of	NULL
PU.1	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
TFE3	NULL
in	NULL
pairwise	NULL
combinations	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
constant	NULL
amounts	NULL
of	NULL
wA-binding	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
wB-binding	NULL
PU.1	NULL
demonstrated	NULL
that	NULL
the	NULL
M100	NULL
,	NULL
+4	NULL
,	NULL
and	NULL
+10	NULL
insertion	NULL
mutants	NULL
bound	NULL
these	NULL
proteins	NULL
with	NULL
indistinguishable	NULL
affinities	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
compare	NULL
M100	NULL
[	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
]	NULL
,	NULL
+4	NULL
[	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
]	NULL
,	NULL
and	NULL
+10	NULL
[	NULL
lanes	NULL
9	NULL
to	NULL
12	NULL
]	NULL
)	NULL
.	NULL

The	NULL
complex	NULL
representing	NULL
the	NULL
PU.1/ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
double	NULL
occupancy	NULL
(	NULL
P/E	NULL
)	NULL
was	NULL
seen	NULL
at	NULL
lower	NULL
concentrations	NULL
of	NULL
PU.1	NULL
compared	NULL
with	NULL
the	NULL
PU.1	NULL
double-occupancy	NULL
band	NULL
(	NULL
2P	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
Ets-1	NULL
binding	NULL
to	NULL
the	NULL
PU.1-occupied	NULL
p.	NULL
enhancer	NULL
is	NULL
preferred	NULL
over	NULL
binding	NULL
of	NULL
a	NULL
second	NULL
molecule	NULL
of	NULL
PU.1	NULL
to	NULL
the	NULL
pA	NULL
site	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
experiments	NULL
with	NULL
constant	NULL
amounts	NULL
of	NULL
PU.1	NULL
and	NULL
increasing	NULL
concentrations	NULL
of	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
or	NULL
full-length	NULL
Ets-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

EMSA	NULL
with	NULL
full	NULL
length	NULL
Ets-1	NULL
and	NULL
PU.1	NULL
also	NULL
showed	NULL
no	NULL
differences	NULL
in	NULL
ETS	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
M100	NULL
or	NULL
spacing	NULL
mutants	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
simultaneous	NULL
binding	NULL
of	NULL
PU.1	NULL
and	NULL
Ets-1	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
functionally	NULL
inactive	NULL
+4-	NULL
or	NULL
+10-bp	NULL
enhancer	NULL
mutants	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
insertions	NULL
affected	NULL
simultaneous	NULL
4548	NULL
NIKOLAJCZYK	NULL
ET	NULL
AL	NULL
.	NULL

wh	NULL
``	NULL
&	NULL
0	NULL
V	NULL
o	NULL
09	NULL
AY	NULL
¥	NULL
o	NULL
&	NULL
A	NULL
W	NULL
x	NULL
>	NULL
&	NULL
of	NULL
?	NULL

C	NULL
&	NULL
\	NULL
'	NULL
,	NULL
P	NULL
A*	NULL
40	NULL
30	NULL
20	NULL
ase	NULL
[	NULL
]	NULL
M1090	NULL
uA	NULL
Relative	NULL
CAT	NULL
Activity	NULL
2	NULL
2	NULL
[	NULL
_	NULL
]	NULL
M100	NULL
[	NULL
+10	NULL
]	NULL
D	NULL
‘	NULL
miooprs	NULL
)	NULL
[	NULL
--	NULL
_	NULL
--	NULL
-_	NULL
--	NULL
--	NULL
H	NULL
ues	NULL
[	NULL
__	NULL
]	NULL
uB	NULL
D	NULL
(	NULL
u70	NULL
)	NULL
2	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
®	NULL
o	NULL
Pu	NULL
ass	NULL
geat	NULL
ad	NULL
o	NULL
b	NULL
‘	NULL
tx/Q	NULL
’	NULL
q	NULL
,	NULL
p/ngégy	NULL
.	NULL

’	NULL
Sr	NULL
,	NULL
\\/	NULL
N.	NULL
b	NULL
(	NULL
L.	NULL
(	NULL
b	NULL
b	NULL
‘	NULL
.	NULL

(	NULL
is	NULL
(	NULL
L.	NULL
40	NULL
30	NULL
20	NULL
7	NULL
Relative	NULL
CAT	NULL
Activity	NULL
ua	NULL
[	NULL
__H	NULL
uE3	NULL
uB-	NULL
D	NULL
“	NULL
ass	NULL
[	NULL
]	NULL
Mm10o	NULL
M1004	NULL
)	NULL
[	NULL
_____	NULL
]	NULL
-	NULL
M100	NULL
[	NULL
+10	NULL
]	NULL
D4	NULL
M100	NULL
[	NULL
+25	NULL
]	NULL
170	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
spacing-mutant	NULL
p.	NULL
enhancer	NULL
constructs	NULL
.	NULL

M100	NULL
and	NULL
spacing	NULL
mutants	NULL
were	NULL
analyzed	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
70	NULL
minimal	NULL
enhancer	NULL
(	NULL
A	NULL
)	NULL
,	NULL
or	NULL
the	NULL
larger	NULL
p.170	NULL
enhancer	NULL
(	NULL
B	NULL
)	NULL
by	NULL
transient	NULL
transfections	NULL
into	NULL
$	NULL
194	NULL
plasmacytoma	NULL
cells	NULL
.	NULL

Relative	NULL
chloramphenicol	NULL
acetyltransferase	NULL
activity	NULL
shown	NULL
on	NULL
the	NULL
y	NULL
axis	NULL
is	NULL
the	NULL
activity	NULL
of	NULL
reporter	NULL
plasmids	NULL
normalized	NULL
to	NULL
an	NULL
enhancerless	NULL
construct	NULL
.	NULL

M100	NULL
and	NULL
spacing-mutant	NULL
constructs	NULL
are	NULL
defined	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
and	NULL
pA~	NULL
,	NULL
F3	NULL
,	NULL
and	NULL
B-	NULL
mutants	NULL
are	NULL
from	NULL
Nelsen	NULL
et	NULL
al	NULL
.	NULL

(	NULL
42	NULL
)	NULL
.	NULL

Data	NULL
presented	NULL
are	NULL
the	NULL
mean	NULL
of	NULL
at	NULL
least	NULL
two	NULL
transfections	NULL
carried	NULL
out	NULL
in	NULL
duplicate	NULL
;	NULL
error	NULL
bars	NULL
represent	NULL
the	NULL
range	NULL
of	NULL
values	NULL
obtained	NULL
in	NULL
these	NULL
experiments	NULL
.	NULL

Numerical	NULL
values	NULL
for	NULL
the	NULL
activity	NULL
and	NULL
range	NULL
are	NULL
shown	NULL
above	NULL
each	NULL
graph	NULL
.	NULL

binding	NULL
of	NULL
PU.1	NULL
and	NULL
TFE3	NULL
,	NULL
we	NULL
used	NULL
a	NULL
splice	NULL
variant	NULL
of	NULL
TFE3	NULL
(	NULL
TFE3S	NULL
)	NULL
(	NULL
47	NULL
)	NULL
and	NULL
PU.1	NULL
in	NULL
EMSA	NULL
.	NULL

TFE3S	NULL
retains	NULL
the	NULL
DNA-binding	NULL
properties	NULL
of	NULL
TFE3	NULL
but	NULL
results	NULL
in	NULL
a	NULL
clearer	NULL
,	NULL
more	NULL
easily	NULL
interpreted	NULL
pattern	NULL
in	NULL
EMSA	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
TFE3S	NULL
was	NULL
held	NULL
constant	NULL
while	NULL
the	NULL
concentration	NULL
of	NULL
PU.1	NULL
was	NULL
increased	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
previous	NULL
analyses	NULL
of	NULL
full-length	NULL
TFE3	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
TFE3S	NULL
alone	NULL
to	NULL
the	NULL
M100	NULL
,	NULL
+4	NULL
,	NULL
or	NULL
+10	NULL
mutations	NULL
was	NULL
unchanged	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
1	NULL
,	NULL
6	NULL
,	NULL
and	NULL
11	NULL
)	NULL
.	NULL

TFE3S	NULL
plus	NULL
low	NULL
concentrations	NULL
of	NULL
PU.1	NULL
formed	NULL
one	NULL
novel	NULL
slowly	NULL
migrating	NULL
complex	NULL
(	NULL
P/T	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

At	NULL
higher	NULL
concentrations	NULL
of	NULL
PU.1	NULL
,	NULL
an	NULL
additional	NULL
complex	NULL
,	NULL
2P/T	NULL
,	NULL
was	NULL
formed	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
the	NULL
initial	NULL
complex	NULL
(	NULL
P/T	NULL
)	NULL
represents	NULL
PU.1	NULL
and	NULL
TFE3S	NULL
binding	NULL
to	NULL
the	NULL
wB	NULL
and	NULL
wE3	NULL
sites	NULL
,	NULL
respectively	NULL
;	NULL
the	NULL
most	NULL
slowly	NULL
migrating	NULL
complex	NULL
,	NULL
2P/T	NULL
,	NULL
represents	NULL
PU.1	NULL
occupying	NULL
both	NULL
mA	NULL
and	NULL
pB	NULL
in	NULL
addition	NULL
to	NULL
TFE3S	NULL
binding	NULL
E3	NULL
.	NULL

Similar	NULL
patterns	NULL
of	NULL
complexes	NULL
were	NULL
generated	NULL
on	NULL
the	NULL
+4	NULL
and	NULL
+10	NULL
spacing	NULL
mutations	NULL
(	NULL
+4	NULL
[	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
]	NULL
,	NULL
+10	NULL
[	NULL
lanes	NULL
11	NULL
to	NULL
15	NULL
]	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
initial	NULL
(	NULL
P/T	NULL
)	NULL
complex	NULL
formed	NULL
by	NULL
PU.1	NULL
and	NULL
TFE3S	NULL
on	NULL
the	NULL
+4	NULL
enhancer	NULL
DNA	NULL
migrated	NULL
faster	NULL
than	NULL
the	NULL
P/T	NULL
complexes	NULL
formed	NULL
on	NULL
either	NULL
the	NULL
M100	NULL
or	NULL
+10	NULL
enhancers	NULL
.	NULL

This	NULL
difference	NULL
was	NULL
not	NULL
seen	NULL
in	NULL
complexes	NULL
containing	NULL
TFE3S	NULL
alone	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
this	NULL
altered	NULL
mobility	NULL
may	NULL
be	NULL
due	NULL
to	NULL
differences	NULL
in	NULL
DNA	NULL
conformation	NULL
induced	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
TFE3	NULL
and	NULL
PU.1	NULL
.	NULL

TFE3	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
bend	NULL
DNA	NULL
(	NULL
11	NULL
,	NULL
48	NULL
)	NULL
,	NULL
but	NULL
the	NULL
DNA-bending	NULL
properties	NULL
of	NULL
PU.1	NULL
are	NULL
unknown	NULL
.	NULL

Because	NULL
the	NULL
TFE3-binding	NULL
site	NULL
in	NULL
the	NULL
+4	NULL
mutant	NULL
is	NULL
rotated	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
wB	NULL
site	NULL
by	NULL
half	NULL
a	NULL
helical	NULL
turn	NULL
compared	NULL
with	NULL
both	NULL
the	NULL
M100	NULL
and	NULL
+10	NULL
mutants	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
the	NULL
bends	NULL
induced	NULL
by	NULL
each	NULL
protein	NULL
may	NULL
neutralize	NULL
each	NULL
other	NULL
and	NULL
thereby	NULL
result	NULL
in	NULL
the	NULL
observed	NULL
differences	NULL
in	NULL
electrophoretic	NULL
migration	NULL
.	NULL

We	NULL
did	NULL
not	NULL
examine	NULL
Ets-1/TFE3	NULL
pairwise	NULL
interactions	NULL
,	NULL
because	NULL
the	NULL
spacing	NULL
mutants	NULL
do	NULL
not	NULL
change	NULL
the	NULL
relative	NULL
configuration	NULL
of	NULL
the	NULL
pA	NULL
and	NULL
E3	NULL
sites	NULL
.	NULL

Overall	NULL
,	NULL
both	NULL
single	NULL
and	NULL
multiple	NULL
protein-DNA	NULL
binding	NULL
assays	NULL
demonstrated	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
binding	NULL
of	NULL
Ets-1	NULL
,	NULL
TFE3	NULL
,	NULL
and/or	NULL
PU.1	NULL
on	NULL
M100	NULL
versus	NULL
the	NULL
insertion	NULL
mutant	NULL
enhancers	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
binding	NULL
analyses	NULL
with	NULL
purified	NULL
proteins	NULL
do	NULL
not	NULL
provide	NULL
a	NULL
simple	NULL
mechanism	NULL
for	NULL
the	NULL
inactivation	NULL
of	NULL
the	NULL
enhancer	NULL
by	NULL
the	NULL
+4	NULL
or	NULL
+10	NULL
mutations	NULL
.	NULL

p.	NULL
enhancer	NULL
DNA	NULL
flexure	NULL
is	NULL
increased	NULL
by	NULL
protein	NULL
binding	NULL
.	NULL

The	NULL
DNA-bending	NULL
model	NULL
proposed	NULL
as	NULL
the	NULL
basis	NULL
for	NULL
the	NULL
differential	NULL
migration	NULL
of	NULL
P/T	NULL
complexes	NULL
formed	NULL
on	NULL
the	NULL
M100	NULL
and	NULL
+4	NULL
mutants	NULL
was	NULL
further	NULL
analyzed	NULL
by	NULL
two	NULL
methods	NULL
:	NULL
circular	NULL
permutation	NULL
and	NULL
phasing	NULL
analyses	NULL
.	NULL

For	NULL
circular	NULL
permutation	NULL
analysis	NULL
,	NULL
the	NULL
minimal	NULL
p.	NULL
enhancer	NULL
was	NULL
inserted	NULL
between	NULL
tandemly	NULL
repeated	NULL
restriction	NULL
sites	NULL
of	NULL
the	NULL
pBend	NULL
vector	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Digestion	NULL
of	NULL
the	NULL
resultant	NULL
plasmid	NULL
with	NULL
various	NULL
endonucleases	NULL
yielded	NULL
fragments	NULL
of	NULL
identical	NULL
size	NULL
,	NULL
with	NULL
the	NULL
minimal	NULL
enhancer	NULL
located	NULL
at	NULL
different	NULL
positions	NULL
(	NULL
Fig	NULL
.	NULL

SA	NULL
)	NULL
.	NULL

Circular	NULL
permutation	NULL
analysis	NULL
detects	NULL
alterations	NULL
in	NULL
protein-DNA	NULL
complex	NULL
mobilities	NULL
that	NULL
reflect	NULL
changes	NULL
in	NULL
end-to-end	NULL
DNA	NULL
distance	NULL
resulting	NULL
from	NULL
(	NULL
i	NULL
)	NULL
protein-induced	NULL
DNA	NULL
structural	NULL
changes	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
the	NULL
changing	NULL
position	NULL
of	NULL
the	NULL
protein-binding	NULL
element	NULL
within	NULL
the	NULL
probe	NULL
.	NULL

The	NULL
shorter	NULL
end-to-end	NULL
distance	NULL
of	NULL
a	NULL
DNA	NULL
molecule	NULL
bent	NULL
at	NULL
its	NULL
center	NULL
is	NULL
detected	NULL
by	NULL
a	NULL
retardation	NULL
of	NULL
that	NULL
molecule	NULL
(	NULL
probe	NULL
3	NULL
)	NULL
compared	NULL
with	NULL
a	NULL
DNA	NULL
molecule	NULL
bent	NULL
at	NULL
one	NULL
end	NULL
(	NULL
probe	NULL
5	NULL
)	NULL
.	NULL

Circular	NULL
permutation	NULL
analysis	NULL
of	NULL
PU.1	NULL
binding	NULL
to	NULL
the	NULL
minimal	NULL
enhancer	NULL
demonstrated	NULL
PU.1-induced	NULL
changes	NULL
in	NULL
DNA	NULL
flexure	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
.	NULL

Calculation	NULL
of	NULL
the	NULL
bend	NULL
angle	NULL
indicated	NULL
that	NULL
PU.1	NULL
binding	NULL
the	NULL
wB	NULL
site	NULL
bent	NULL
enhancer	NULL
DNA	NULL
by	NULL
approximately	NULL
48°	NULL
.	NULL

Similar	NULL
analysis	NULL
of	NULL
TFE3S	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
demonstrated	NULL
that	NULL
this	NULL
bHLH-zip	NULL
protein	NULL
bent	NULL
the	NULL
p	NULL
enhancer	NULL
by	NULL
40°	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
second	NULL
bHLH-zip	NULL
protein	NULL
,	NULL
USF	NULL
,	NULL
induced	NULL
a	NULL
60°	NULL
DNA	NULL
bend	NULL
when	NULL
bound	NULL
to	NULL
the	NULL
E3	NULL
site	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
extent	NULL
of	NULL
DNA	NULL
bending	NULL
was	NULL
not	NULL
determined	NULL
solely	NULL
by	NULL
the	NULL
DNA	NULL
sequence	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
PU.1-induced	NULL
increase	NULL
in	NULL
p	NULL
enhancer	NULL
flexure	NULL
is	NULL
a	NULL
property	NULL
of	NULL
the	NULL
ETS	NULL
domain	NULL
of	NULL
PU.1	NULL
specifically	NULL
or	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
A	NULL
PU	NULL
.	NULL

1	NULL
/|/|/|	NULL
ETS	NULL
(	NULL
EtS-1	NULL
)	NULL
++++++++++++	NULL
2p-	NULL
»	NULL
bg	NULL
bog	NULL
fnd	NULL
orr	NULL
L	NULL
.	NULL

ALI	NULL
)	NULL
I—bwmq	NULL
tat	NULL
p	NULL
E-	NULL
Snl	NULL
s	NULL
Roll	NULL
b	NULL
%	NULL
w.	NULL
“	NULL
-	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
M100	NULL
+4	NULL
+10	NULL
8	NULL
PU1—/I	NULL
/I	NULL
/I	NULL
TFE3§	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
4	NULL
+	NULL
4+	NULL
4+	NULL
+	NULL
+	NULL
2P/T	NULL
b	NULL
#	NULL
P/T	NULL
-m	NULL
i	NULL
6	NULL
b	NULL
T	NULL
-	NULL
»	NULL
With	NULL
ind	NULL
tgp	NULL
i	NULL
tel	NULL
ba	NULL
,	NULL
-	NULL
»	NULL
hed	NULL
wa	NULL
2P	NULL
P	NULL
-t-	NULL
-	NULL
and	NULL
-	NULL
~	NULL
<	NULL
>	NULL
tal	NULL
tnat	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12131415	NULL
M100	NULL
+4	NULL
+10	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Coordinate	NULL
binding	NULL
of	NULL
two	NULL
proteins	NULL
to	NULL
the	NULL
p.	NULL
enhancer	NULL
spacing	NULL
mutants	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Binding	NULL
of	NULL
the	NULL
ETS	NULL
domain	NULL
of	NULL
Ets-1	NULL
,	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
,	NULL
to	NULL
the	NULL
M100	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
,	NULL
+4	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
,	NULL
or	NULL
+10	NULL
(	NULL
lanes	NULL
9	NULL
to	NULL
12	NULL
)	NULL
mutant	NULL
jw	NULL
enhancers	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
PU.1	NULL
.	NULL

ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
bound	NULL
to	NULL
the	NULL
mA	NULL
site	NULL
is	NULL
designated	NULL
complex	NULL
E	NULL
,	NULL
with	NULL
P	NULL
and	NULL
2P	NULL
indicating	NULL
single	NULL
and	NULL
double	NULL
occupancy	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
the	NULL
B	NULL
(	NULL
and	NULL
mA	NULL
)	NULL
sites	NULL
by	NULL
PU.1	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2D	NULL
.	NULL

The	NULL
ternary	NULL
complex	NULL
containing	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
,	NULL
PU.1	NULL
,	NULL
and	NULL
the	NULL
p.	NULL
enhancer	NULL
is	NULL
labeled	NULL
P/E	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Binding	NULL
of	NULL
TFE3	NULL
(	NULL
TFE3S	NULL
)	NULL
alone	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
6	NULL
,	NULL
and	NULL
11	NULL
)	NULL
or	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
PU.1	NULL
on	NULL
the	NULL
M100	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
,	NULL
+4	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
,	NULL
or	NULL
+10	NULL
(	NULL
lanes	NULL
11	NULL
to	NULL
15	NULL
)	NULL
mutant	NULL
p	NULL
enhancers	NULL
.	NULL

Formation	NULL
of	NULL
single-	NULL
and	NULL
double-occupancy	NULL
PU.1	NULL
complexes	NULL
are	NULL
designated	NULL
P	NULL
and	NULL
2P	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
ternary	NULL
PU.1-TFE3-u	NULL
enhancer	NULL
complex	NULL
is	NULL
labeled	NULL
P/T	NULL
,	NULL
and	NULL
the	NULL
quaternary	NULL
2PU.1-TFE3-p	NULL
enhancer	NULL
complex	NULL
is	NULL
marked	NULL
2P/T	NULL
.	NULL

A	NULL
splice	NULL
variant	NULL
of	NULL
TFE3	NULL
which	NULL
contains	NULL
an	NULL
intact	NULL
bHLH-zip	NULL
DNA-binding	NULL
domain	NULL
was	NULL
used	NULL
in	NULL
these	NULL
assays	NULL
.	NULL

a	NULL
general	NULL
property	NULL
of	NULL
ETS	NULL
domains	NULL
,	NULL
we	NULL
repeated	NULL
circular	NULL
permutation	NULL
analyses	NULL
with	NULL
the	NULL
ETS	NULL
domain	NULL
of	NULL
PU.1	NULL
[	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
]	NULL
and	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

ETS	NULL
(	NULL
PU.1	NULL
)	NULL
-DNA	NULL
complexes	NULL
showed	NULL
variable	NULL
mobility	NULL
with	NULL
probes	NULL
1	NULL
to	NULL
5	NULL
,	NULL
as	NULL
seen	NULL
for	NULL
the	NULL
full-length	NULL
PU.1	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
all	NULL
complexes	NULL
with	NULL
the	NULL
ETS	NULL
domain	NULL
of	NULL
Ets-1	NULL
migrated	NULL
at	NULL
approximately	NULL
the	NULL
same	NULL
position	NULL
,	NULL
indicating	NULL
that	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
did	NULL
not	NULL
induce	NULL
a	NULL
conformational	NULL
change	NULL
in	NULL
the	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
that	NULL
PU.1-induced	NULL
flexure	NULL
change	NULL
was	NULL
not	NULL
determined	NULL
by	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
mB	NULL
element	NULL
,	NULL
we	NULL
analyzed	NULL
a	NULL
different	NULL
PU.1-binding	NULL
site	NULL
.	NULL

Circular	NULL
permutation	NULL
analysis	NULL
indicated	NULL
that	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
bent	NULL
DNA	NULL
containing	NULL
the	NULL
w	NULL
ENHANCER	NULL
ACTIVATION	NULL
REQUIRES	NULL
SITE	NULL
ALIGNMENT	NULL
4549	NULL
SV40-PU.1	NULL
site	NULL
to	NULL
an	NULL
apparent	NULL
angle	NULL
of	NULL
40°	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
bending	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
ETS	NULL
domain	NULL
of	NULL
PU.1	NULL
rather	NULL
than	NULL
by	NULL
the	NULL
corresponding	NULL
DNA	NULL
element	NULL
.	NULL

Circular	NULL
permutation	NULL
results	NULL
were	NULL
further	NULL
analyzed	NULL
to	NULL
determine	NULL
the	NULL
center	NULL
of	NULL
the	NULL
protein-induced	NULL
DNA	NULL
bend	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

Although	NULL
this	NULL
analysis	NULL
can	NULL
not	NULL
precisely	NULL
localize	NULL
the	NULL
bend	NULL
cen-ter	NULL
,	NULL
our	NULL
results	NULL
show	NULL
that	NULL
the	NULL
PU.1-induced	NULL
bend	NULL
lies	NULL
within	NULL
the	NULL
B	NULL
element	NULL
(	NULL
TTTGGGGAA	NULL
)	NULL
.	NULL

The	NULL
TFE3-induced	NULL
bend	NULL
center	NULL
is	NULL
located	NULL
a	NULL
few	NULL
nucleotides	NULL
5	NULL
'	NULL
from	NULL
the	NULL
core	NULL
CATGTG	NULL
of	NULL
the	NULL
bHLH-zip	NULL
binding	NULL
site	NULL
,	NULL
E3	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
two	NULL
of	NULL
the	NULL
three	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
minimal	NULL
p	NULL
enhancer	NULL
induce	NULL
conformational	NULL
changes	NULL
in	NULL
the	NULL
DNA	NULL
.	NULL

Only	NULL
PU.1	NULL
induces	NULL
a	NULL
directed	NULL
bend	NULL
in	NULL
p.	NULL
enhancer	NULL
DNA	NULL
.	NULL

Although	NULL
circular	NULL
permutation	NULL
analysis	NULL
provides	NULL
evidence	NULL
for	NULL
protein-induced	NULL
DNA	NULL
distortion	NULL
,	NULL
this	NULL
assay	NULL
more	NULL
accurately	NULL
reflects	NULL
changes	NULL
in	NULL
DNA	NULL
flexure	NULL
that	NULL
result	NULL
from	NULL
protein-DNA	NULL
interactions	NULL
.	NULL

Alternatively	NULL
,	NULL
anomalous	NULL
migrations	NULL
in	NULL
circular	NULL
permutation	NULL
assays	NULL
may	NULL
result	NULL
from	NULL
the	NULL
nonglobular	NULL
conformations	NULL
of	NULL
some	NULL
DNA-binding	NULL
proteins	NULL
(	NULL
26	NULL
)	NULL
.	NULL

To	NULL
distinguish	NULL
between	NULL
DNA	NULL
distortion	NULL
and	NULL
directed	NULL
DNA	NULL
bending	NULL
,	NULL
we	NULL
performed	NULL
phasing	NULL
analysis	NULL
.	NULL

For	NULL
phasing	NULL
analysis	NULL
,	NULL
the	NULL
p.	NULL
enhancer	NULL
fragment	NULL
was	NULL
cloned	NULL
adjacent	NULL
to	NULL
three	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tracts	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Each	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tract	NULL
confers	NULL
an	NULL
intrinsic	NULL
DNA	NULL
bend	NULL
of	NULL
18°	NULL
,	NULL
for	NULL
an	NULL
overall	NULL
54°	NULL
minor-groove-directed	NULL
DNA	NULL
bend	NULL
.	NULL

This	NULL
bend	NULL
serves	NULL
as	NULL
an	NULL
internal	NULL
standard	NULL
against	NULL
which	NULL
protein-induced	NULL
bending	NULL
in	NULL
the	NULL
adjacent	NULL
DNA	NULL
fragment	NULL
can	NULL
be	NULL
compared	NULL
.	NULL

The	NULL
p	NULL
enhancer	NULL
was	NULL
cloned	NULL
at	NULL
five	NULL
different	NULL
distances	NULL
from	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tracts	NULL
to	NULL
position	NULL
it	NULL
at	NULL
various	NULL
helical	NULL
positions	NULL
relative	NULL
to	NULL
the	NULL
intrinsic	NULL
minor-groove	NULL
bend	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Protein-induced	NULL
bends	NULL
directed	NULL
toward	NULL
the	NULL
minor	NULL
groove	NULL
reinforce	NULL
the	NULL
intrinsic	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tract	NULL
bend	NULL
when	NULL
the	NULL
protein-binding	NULL
site	NULL
is	NULL
positioned	NULL
at	NULL
integral	NULL
(	NULL
n	NULL
)	NULL
helical	NULL
turns	NULL
from	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tracts	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
major-groove	NULL
bends	NULL
reinforce	NULL
the	NULL
intrinsic	NULL
bend	NULL
when	NULL
the	NULL
protein-binding	NULL
site	NULL
is	NULL
positioned	NULL
on	NULL
the	NULL
opposite	NULL
helical	NULL
face	NULL
(	NULL
n	NULL
+	NULL
5	NULL
)	NULL
.	NULL

If	NULL
a	NULL
DNA-binding	NULL
protein	NULL
induces	NULL
only	NULL
a	NULL
change	NULL
in	NULL
flexure	NULL
,	NULL
the	NULL
location	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tracts	NULL
does	NULL
not	NULL
affect	NULL
DNA	NULL
bending	NULL
as	NULL
assayed	NULL
by	NULL
nucleoprotein	NULL
complex	NULL
migration	NULL
.	NULL

EMSA	NULL
analysis	NULL
demonstrates	NULL
bend	NULL
reinforcement	NULL
as	NULL
decreased	NULL
mobility	NULL
of	NULL
the	NULL
DNA-protein	NULL
complex	NULL
.	NULL

We	NULL
performed	NULL
phasing	NULL
analysis	NULL
with	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
,	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
,	NULL
and	NULL
TFE3S	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Differences	NULL
in	NULL
protein-DNA	NULL
complex	NULL
mobility	NULL
were	NULL
apparent	NULL
for	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
but	NULL
not	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
or	NULL
TFE3S	NULL
(	NULL
lanes	NULL
11	NULL
to	NULL
15	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
only	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
induced	NULL
a	NULL
directed	NULL
DNA	NULL
bend	NULL
.	NULL

Results	NULL
similar	NULL
to	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
results	NULL
were	NULL
obtained	NULL
for	NULL
full-length	NULL
PU.1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
PU.1-DNA	NULL
complex	NULL
was	NULL
specifically	NULL
inhibited	NULL
by	NULL
the	NULL
p.	NULL
enhancer	NULL
phasing	NULL
plasmid	NULL
but	NULL
not	NULL
an	NULL
AP-1	NULL
site-containing	NULL
plasmid	NULL
,	NULL
indicating	NULL
that	NULL
PU.1	NULL
binds	NULL
only	NULL
u	NULL
enhancer	NULL
elements	NULL
in	NULL
the	NULL
phasing	NULL
fragments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Phasing	NULL
analysis	NULL
further	NULL
allowed	NULL
us	NULL
to	NULL
calculate	NULL
the	NULL
degree	NULL
of	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
-induced	NULL
DNA	NULL
bending	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
best-fit	NULL
cosine	NULL
curve	NULL
for	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
indicated	NULL
a	NULL
bend	NULL
angle	NULL
of	NULL
24°	NULL
,	NULL
after	NULL
correction	NULL
for	NULL
the	NULL
slight	NULL
bend	NULL
(	NULL
1.0°	NULL
)	NULL
contributed	NULL
by	NULL
the	NULL
DNA	NULL
probe	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

The	NULL
direction	NULL
of	NULL
the	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
-induced	NULL
DNA	NULL
bend	NULL
can	NULL
also	NULL
be	NULL
ascertained	NULL
from	NULL
the	NULL
phasing	NULL
analysis	NULL
once	NULL
the	NULL
center	NULL
of	NULL
the	NULL
bend	NULL
has	NULL
been	NULL
determined	NULL
.	NULL

Although	NULL
circular	NULL
permutation	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
center	NULL
of	NULL
the	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
-induced	NULL
flexure	NULL
lies	NULL
within	NULL
the	NULL
mB	NULL
element	NULL
,	NULL
the	NULL
precise	NULL
bend	NULL
center	NULL
of	NULL
this	NULL
nonpalindromic	NULL
site	NULL
could	NULL
not	NULL
be	NULL
determined	NULL
.	NULL

However	NULL
,	NULL
PU.1	NULL
binding	NULL
to	NULL
the	NULL
pB	NULL
site	NULL
induces	NULL
a	NULL
strong	NULL
DNase	NULL
I-hypersensitive	NULL
site	NULL
in	NULL
the	NULL
noncoding	NULL
strand	NULL
between	NULL
the	NULL
C	NULL
and	NULL
A	NULL
residues	NULL
,	NULL
suggesting	NULL
the	NULL
presence	NULL
of	NULL
protein-induced	NULL
distortion	NULL
of	NULL
the	NULL
phosphodiester	NULL
backbone	NULL
4550	NULL
NIKOLAJCZYK	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
uB	NULL
uE3	NULL
uA	NULL
uB	NULL
4E3	NULL
uA	NULL
|	NULL
C	NULL
0	NULL
0	NULL
]	NULL
uB_uE3	NULL
uA	NULL
--	NULL
|	NULL
C	NULL
o	NULL
0|	NULL
uB	NULL
uE3	NULL
uA	NULL
|	NULL
C	NULL
a	NULL
0	NULL
]	NULL
uB	NULL
uE3	NULL
uA	NULL
C	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
ETS	NULL
(	NULL
Ets1	NULL
)	NULL
D	NULL
op	NULL
--	NULL
Probe	NULL
1	NULL
2	NULL
3	NULL
4	NULL
§	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
win	NULL
~	NULL
,	NULL
w.k	NULL
‘	NULL
~	NULL
E	NULL
>	NULL
.	NULL

g	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
p33	NULL
has	NULL
2	NULL
a	NULL
.	NULL

4.8	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

ENZYME	NULL
(	NULL
probe	NULL
)	NULL
B	NULL
PU.1	NULL
TFE3S	NULL
Fo	NULL
4	NULL
Mie	NULL
p	NULL
)	NULL
Probe	NULL
|	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Spe	NULL
|	NULL
(	NULL
2	NULL
)	NULL
Jovi	NULL
booed	NULL
bal	NULL
|	NULL
,	NULL
io	NULL
ath	NULL
GR	NULL
bys	NULL
EcoR	NULL
V	NULL
(	NULL
3	NULL
)	NULL
¥	NULL
Nru	NULL
I	NULL
(	NULL
4	NULL
)	NULL
BamHI	NULL
(	NULL
5	NULL
)	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
H	NULL
-	NULL
PU	NULL
mobility	NULL
®	NULL
_	NULL
TFE3	NULL
mobility	NULL
(	NULL
wa	NULL
)	NULL
seasL	NULL
20	NULL
I	NULL
*	NULL
T	NULL
*	NULL
T	NULL
T	NULL
*	NULL
T	NULL
r	NULL
3.5	NULL
40	NULL
so	NULL
/	NULL
_	NULL
so	NULL
\	NULL
100	NULL
120	NULL
140	NULL
CATGTG	NULL
...	NULL
...	NULL
.GGAA	NULL
Distance	NULL
from	NULL
end	NULL
(	NULL
base	NULL
pairs	NULL
)	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Circular	NULL
permutation	NULL
of	NULL
PU.1	NULL
binding	NULL
to	NULL
the	NULL
p.	NULL
enhancer	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Probes	NULL
used	NULL
in	NULL
circular	NULL
permutation	NULL
assays	NULL
.	NULL

Fragments	NULL
1	NULL
to	NULL
5	NULL
containing	NULL
pA	NULL
,	NULL
E3	NULL
,	NULL
and	NULL
mB	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
pBend	NULL
vector	NULL
with	NULL
the	NULL
designated	NULL
enzymes	NULL
.	NULL

The	NULL
wB	NULL
site	NULL
is	NULL
located	NULL
closest	NULL
to	NULL
the	NULL
end	NULL
of	NULL
the	NULL
fragment	NULL
in	NULL
probe	NULL
5	NULL
and	NULL
closest	NULL
to	NULL
the	NULL
middle	NULL
of	NULL
the	NULL
fragment	NULL
in	NULL
probe	NULL
3	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
Circular	NULL
permutation	NULL
analysis	NULL
.	NULL

Probes	NULL
1	NULL
to	NULL
5	NULL
were	NULL
incubated	NULL
with	NULL
PU.1	NULL
(	NULL
B	NULL
)	NULL
,	NULL
TFE3S	NULL
(	NULL
B	NULL
)	NULL
,	NULL
the	NULL
ETS	NULL
domain	NULL
of	NULL
PU.1	NULL
(	NULL
C	NULL
)	NULL
,	NULL
or	NULL
the	NULL
ETS	NULL
domain	NULL
of	NULL
Ets-1	NULL
(	NULL
C	NULL
)	NULL
and	NULL
assayed	NULL
by	NULL
electrophoresis	NULL
through	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Determination	NULL
of	NULL
the	NULL
bend	NULL
center	NULL
for	NULL
PU.1	NULL
and	NULL
TFE3S	NULL
.	NULL

The	NULL
mobilities	NULL
of	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
generated	NULL
with	NULL
the	NULL
circular	NULL
permutation	NULL
probes	NULL
were	NULL
plotted	NULL
as	NULL
a	NULL
function	NULL
of	NULL
the	NULL
distance	NULL
between	NULL
the	NULL
core	NULL
GGAA	NULL
of	NULL
the	NULL
wB	NULL
and	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
each	NULL
probe	NULL
.	NULL

(	NULL
45a	NULL
)	NULL
.	NULL

We	NULL
approximated	NULL
the	NULL
hypersensitive	NULL
site	NULL
as	NULL
the	NULL
center	NULL
of	NULL
the	NULL
PU.1-induced	NULL
DNA	NULL
bend	NULL
and	NULL
calculated	NULL
the	NULL
spacer	NULL
lengths	NULL
between	NULL
pB	NULL
and	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tract	NULL
bend	NULL
centers	NULL
with	NULL
reference	NULL
to	NULL
the	NULL
position	NULL
of	NULL
this	NULL
site	NULL
.	NULL

The	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
-induced	NULL
DNA	NULL
bend	NULL
reinforced	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tract	NULL
bend	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
lowest-mo-bility	NULL
nucleoprotein	NULL
complex	NULL
when	NULL
the	NULL
wB	NULL
site	NULL
was	NULL
positioned	NULL
36	NULL
bp	NULL
(	NULL
3.4	NULL
helical	NULL
turns	NULL
)	NULL
from	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tract	NULL
.	NULL

Because	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
reinforced	NULL
the	NULL
minor-groove-directed	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tract	NULL
bend	NULL
when	NULL
the	NULL
mB	NULL
element	NULL
was	NULL
on	NULL
the	NULL
opposite	NULL
side	NULL
of	NULL
the	NULL
DNA	NULL
helix	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
bends	NULL
m	NULL
enhancer	NULL
DNA	NULL
toward	NULL
the	NULL
major	NULL
groove	NULL
.	NULL

Surprisingly	NULL
,	NULL
TFE3S	NULL
did	NULL
not	NULL
induce	NULL
a	NULL
significant	NULL
directed	NULL
DNA	NULL
bend	NULL
(	NULL
<	NULL
1°	NULL
)	NULL
as	NULL
measured	NULL
by	NULL
phasing	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
;	NULL
cosine	NULL
curve	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
despite	NULL
a	NULL
greater	NULL
than	NULL
40°	NULL
change	NULL
in	NULL
flexure	NULL
calculated	NULL
from	NULL
the	NULL
circular	NULL
permutation	NULL
studies	NULL
.	NULL

This	NULL
result	NULL
conflicts	NULL
with	NULL
earlier	NULL
reports	NULL
(	NULL
11	NULL
,	NULL
48	NULL
)	NULL
of	NULL
DNA	NULL
bending	NULL
by	NULL
bHLH-zip	NULL
proteins	NULL
.	NULL

We	NULL
surmise	NULL
that	NULL
a	NULL
significant	NULL
proportion	NULL
of	NULL
the	NULL
TFE3-induced	NULL
conformational	NULL
change	NULL
may	NULL
be	NULL
attributed	NULL
to	NULL
a	NULL
change	NULL
in	NULL
DNA	NULL
flexure	NULL
.	NULL

Alternatively	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
sequences	NULL
flanking	NULL
the	NULL
bHLH-zip	NULL
recognition	NULL
element	NULL
determine	NULL
the	NULL
extent	NULL
of	NULL
the	NULL
protein-induced	NULL
bend	NULL
.	NULL

DISCUSSION	NULL
To	NULL
facilitate	NULL
mechanistic	NULL
analysis	NULL
of	NULL
the	NULL
lymphoid	NULL
cell-specific	NULL
immunoglobulin	NULL
p	NULL
heavy-chain	NULL
gene	NULL
enhancer	NULL
,	NULL
we	NULL
previously	NULL
described	NULL
a	NULL
minimal	NULL
enhancer	NULL
that	NULL
contains	NULL
three	NULL
sequence	NULL
elements	NULL
:	NULL
pA	NULL
,	NULL
wE3	NULL
,	NULL
and	NULL
wB	NULL
(	NULL
42	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
appropriate	NULL
spatial	NULL
organization	NULL
of	NULL
the	NULL
pA	NULL
and	NULL
pB	NULL
sites	NULL
is	NULL
required	NULL
for	NULL
u	NULL
enhancer	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
vitro	NULL
analysis	NULL
of	NULL
purified	NULL
Ets-1	NULL
,	NULL
TFE3	NULL
,	NULL
and	NULL
PU.1	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
pA	NULL
,	NULL
uE3	NULL
,	NULL
and	NULL
B	NULL
sites	NULL
,	NULL
respectively	NULL
,	NULL
showed	NULL
that	NULL
PU.1	NULL
but	NULL
neither	NULL
Ets-1	NULL
nor	NULL
TFE3	NULL
induced	NULL
a	NULL
directed	NULL
bend	NULL
of	NULL
approximately	NULL
24°	NULL
in	NULL
the	NULL
enhancer	NULL
DNA	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
the	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
A	NULL
yA	NULL
puE3	NULL
uB	NULL
Ag	NULL
Ag	NULL
Ag	NULL
£2.23	NULL
29	NULL
bp	NULL
uA	NULL
uE3	NULL
uB	NULL
-	NULL
Ag	NULL
A	NULL
,	NULL
A	NULL
;	NULL
___	NULL
]	NULL
34	NULL
bp	NULL
uA	NULL
uE3	NULL
uB	NULL
Ag	NULL
Ag	NULL
Ag	NULL
|	NULL
0	NULL
ao	NULL
O	NULL
]	NULL
36	NULL
bp	NULL
uA	NULL
LE3	NULL
uB	NULL
Ag	NULL
A	NULL
;	NULL
Ap	NULL
|C	NULL
o	NULL
©	NULL
]	NULL
39	NULL
bp	NULL
uA	NULL
uE3	NULL
uB	NULL
Ag	NULL
Ag	NULL
Ag	NULL
|	NULL
0	NULL
a	NULL
O	NULL
]	NULL
41	NULL
bp	NULL
B	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
-	NULL
ETS	NULL
(	NULL
Els1	NULL
)	NULL
_	NULL
TFE3S	NULL
SpacerLength	NULL
(	NULL
bp	NULL
)	NULL
29	NULL
34	NULL
36	NULL
39	NULL
41	NULL
58	NULL
63	NULL
65	NULL
68	NULL
70	NULL
45	NULL
50	NULL
52	NULL
55	NULL
57	NULL
Slig	NULL
od	NULL
ul	NULL
s	NULL
p	NULL
1	NULL
2	NULL
8	NULL
4	NULL
50	NULL
6	NULL
7	NULL
B	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Phasing	NULL
analysis	NULL
of	NULL
p.	NULL
enhancer-binding	NULL
proteins	NULL
.	NULL

(	NULL
A	NULL
)	NULL
DNA	NULL
fragments	NULL
used	NULL
in	NULL
the	NULL
phasing	NULL
analysis	NULL
.	NULL

The	NULL
55-bp	NULL
enhancer	NULL
fragment	NULL
was	NULL
inserted	NULL
5	NULL
'	NULL
to	NULL
three	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tracts	NULL
in	NULL
previously	NULL
described	NULL
vectors	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Spacing	NULL
between	NULL
the	NULL
w	NULL
enhancer	NULL
and	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tracts	NULL
was	NULL
varied	NULL
to	NULL
orient	NULL
j.	NULL
enhancer	NULL
elements	NULL
at	NULL
different	NULL
positions	NULL
of	NULL
the	NULL
DNA	NULL
helix	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tracts	NULL
.	NULL

The	NULL
number	NULL
of	NULL
base	NULL
pairs	NULL
between	NULL
the	NULL
center	NULL
of	NULL
the	NULL
core	NULL
GGAA	NULL
of	NULL
B	NULL
and	NULL
the	NULL
center	NULL
of	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tracts	NULL
is	NULL
indicated	NULL
.	NULL

This	NULL
spacer	NULL
length	NULL
varied	NULL
for	NULL
pB	NULL
,	NULL
pA	NULL
or	NULL
E3	NULL
elements	NULL
as	NULL
noted	NULL
in	NULL
panel	NULL
B	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
with	NULL
DNA-phasing	NULL
probes	NULL
.	NULL

Phasing	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
ETS	NULL
(	NULL
PU.1	NULL
)	NULL
(	NULL
spacer	NULL
length	NULL
29	NULL
to	NULL
41	NULL
)	NULL
,	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
(	NULL
spacer	NULL
length	NULL
58	NULL
to	NULL
70	NULL
)	NULL
,	NULL
or	NULL
TFE3S	NULL
(	NULL
spacer	NULL
length	NULL
45	NULL
to	NULL
57	NULL
)	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
through	NULL
20-cm	NULL
4	NULL
%	NULL
acrylamide	NULL
gels	NULL
.	NULL

The	NULL
migration	NULL
of	NULL
each	NULL
complex	NULL
in	NULL
EMSA	NULL
reflects	NULL
the	NULL
net	NULL
bend	NULL
of	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tracts	NULL
plus	NULL
the	NULL
protein-induced	NULL
bend	NULL
.	NULL

PU.1-induced	NULL
bend	NULL
in	NULL
the	NULL
DNA	NULL
facilitates	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
functional	NULL
multiprotein	NULL
complex	NULL
on	NULL
the	NULL
p.	NULL
enhancer	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
rotational	NULL
alignment	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
has	NULL
been	NULL
investigated	NULL
in	NULL
several	NULL
systems	NULL
.	NULL

Most	NULL
of	NULL
these	NULL
studies	NULL
have	NULL
focused	NULL
on	NULL
promoters	NULL
and	NULL
found	NULL
that	NULL
appropriate	NULL
helical	NULL
phasing	NULL
is	NULL
required	NULL
for	NULL
optimal	NULL
activity	NULL
,	NULL
for	NULL
example	NULL
,	NULL
the	NULL
serine	NULL
protease	NULL
B	NULL
gene	NULL
,	NULL
the	NULL
araBAD	NULL
operon	NULL
,	NULL
and	NULL
the	NULL
HLA-DR	NULL
gene	NULL
(	NULL
19	NULL
,	NULL
30	NULL
,	NULL
57	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
helical	NULL
periodicity	NULL
has	NULL
been	NULL
observed	NULL
for	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
promoter	NULL
and	NULL
enhancer	NULL
of	NULL
simian	NULL
virus	NULL
40	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
45	NULL
,	NULL
55	NULL
)	NULL
.	NULL

A	NULL
functional	NULL
role	NULL
for	NULL
strict	NULL
stereochemical	NULL
relationship	NULL
between	NULL
motifs	NULL
within	NULL
an	NULL
enhancer	NULL
has	NULL
been	NULL
harder	NULL
to	NULL
demonstrate	NULL
,	NULL
perhaps	NULL
because	NULL
of	NULL
the	NULL
complex	NULL
organization	NULL
of	NULL
w	NULL
ENHANCER	NULL
ACTIVATION	NULL
REQUIRES	NULL
SITE	NULL
ALIGNMENT	NULL
4551	NULL
enhancers	NULL
.	NULL

Several	NULL
earlier	NULL
studies	NULL
have	NULL
addressed	NULL
this	NULL
question	NULL
as	NULL
summarized	NULL
below	NULL
.	NULL

In	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
«	NULL
-chain	NULL
gene	NULL
enhancer	NULL
,	NULL
a	NULL
requirement	NULL
for	NULL
appropriate	NULL
orientation	NULL
of	NULL
the	NULL
Tal	NULL
and	NULL
Ta2	NULL
domains	NULL
was	NULL
suggested	NULL
by	NULL
altering	NULL
the	NULL
spacing	NULL
between	NULL
these	NULL
elements	NULL
.	NULL

Functional	NULL
assays	NULL
indicated	NULL
that	NULL
for	NULL
enhancer	NULL
activation	NULL
,	NULL
Tal	NULL
and	NULL
Ta2	NULL
elements	NULL
must	NULL
be	NULL
separated	NULL
by	NULL
more	NULL
than	NULL
23	NULL
bp	NULL
but	NULL
less	NULL
than	NULL
93	NULL
bp	NULL
,	NULL
without	NULL
a	NULL
strict	NULL
dependence	NULL
on	NULL
the	NULL
helical	NULL
phasing	NULL
between	NULL
the	NULL
two	NULL
sites	NULL
(	NULL
22	NULL
)	NULL
.	NULL

A	NULL
more	NULL
recent	NULL
analysis	NULL
of	NULL
the	NULL
TCR	NULL
«	NULL
enhancer	NULL
(	NULL
14	NULL
)	NULL
showed	NULL
that	NULL
introduction	NULL
of	NULL
4	NULL
nucleotides	NULL
between	NULL
the	NULL
ATF/CREB	NULL
and	NULL
LEF/PEBP2/	NULL
Ets-1	NULL
sites	NULL
reduced	NULL
enhancer	NULL
activity	NULL
;	NULL
activity	NULL
was	NULL
restored	NULL
by	NULL
increasing	NULL
the	NULL
spacing	NULL
to	NULL
10	NULL
nucleotides	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
optimal	NULL
interaction	NULL
between	NULL
proteins	NULL
bound	NULL
at	NULL
the	NULL
ATF/	NULL
CREB	NULL
site	NULL
and	NULL
at	NULL
one	NULL
or	NULL
more	NULL
of	NULL
the	NULL
other	NULL
sites	NULL
requires	NULL
appropriate	NULL
helical	NULL
phasing	NULL
.	NULL

Schanke	NULL
and	NULL
VanNess	NULL
(	NULL
50	NULL
)	NULL
showed	NULL
that	NULL
large	NULL
changes	NULL
in	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
kB	NULL
and	NULL
E2	NULL
elements	NULL
in	NULL
the	NULL
Ig	NULL
x	NULL
light-chain	NULL
enhancer	NULL
resulted	NULL
in	NULL
loss	NULL
of	NULL
enhancer	NULL
activity	NULL
whereas	NULL
small	NULL
changes	NULL
in	NULL
their	NULL
relative	NULL
positions	NULL
did	NULL
not	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
x	NULL
intron	NULL
enhancer	NULL
does	NULL
not	NULL
have	NULL
strict	NULL
spacing	NULL
requirements	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
close	NULL
juxtaposition	NULL
of	NULL
core-binding	NULL
factor	NULL
sites	NULL
to	NULL
other	NULL
sites	NULL
has	NULL
been	NULL
noted	NULL
in	NULL
the	NULL
TCR	NULL
B-	NULL
and	NULL
8-chain	NULL
gene	NULL
enhancers	NULL
(	NULL
21	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
cooperative	NULL
binding	NULL
of	NULL
Ets-1	NULL
and	NULL
core-binding	NULL
factor	NULL
to	NULL
the	NULL
TCR	NULL
B	NULL
enhancer	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
the	NULL
distance	NULL
between	NULL
the	NULL
two	NULL
sites	NULL
;	NULL
however	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
moving	NULL
the	NULL
sites	NULL
apart	NULL
in	NULL
transcriptional	NULL
activation	NULL
studies	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
determined	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
30-bp	NULL
3E3	NULL
element	NULL
was	NULL
abrogated	NULL
by	NULL
moving	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
c-myb	NULL
and	NULL
core-binding	NULL
factor	NULL
by	NULL
either	NULL
5	NULL
or	NULL
10	NULL
bp	NULL
.	NULL

We	NULL
found	NULL
that	NULL
introduction	NULL
of	NULL
4	NULL
or	NULL
10	NULL
nucleotides	NULL
between	NULL
the	NULL
uA/uE3	NULL
elements	NULL
and	NULL
the	NULL
pB	NULL
element	NULL
essentially	NULL
abolished	NULL
the	NULL
activity	NULL
of	NULL
both	NULL
the	NULL
p70	NULL
minimal	NULL
enhancer	NULL
and	NULL
the	NULL
larger	NULL
170	NULL
enhancer	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Because	NULL
mutation	NULL
of	NULL
the	NULL
E3	NULL
element	NULL
did	NULL
not	NULL
affect	NULL
170	NULL
enhancer	NULL
activity	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
the	NULL
insertion	NULL
mutations	NULL
inactivate	NULL
the	NULL
p.	NULL
enhancer	NULL
by	NULL
disrupting	NULL
interactions	NULL
between	NULL
ETS-domain	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
pA	NULL
and	NULL
pB	NULL
sites	NULL
.	NULL

Such	NULL
interactions	NULL
may	NULL
create	NULL
a	NULL
hybrid	NULL
transactivation	NULL
domain	NULL
formed	NULL
by	NULL
ETS	NULL
proteins	NULL
bound	NULL
to	NULL
both	NULL
sites	NULL
,	NULL
which	NULL
could	NULL
activate	NULL
transcription	NULL
by	NULL
directly	NULL
interacting	NULL
with	NULL
the	NULL
basal	NULL
transcription	NULL
machinery	NULL
.	NULL

Alternatively	NULL
,	NULL
a	NULL
third	NULL
coac-tivator	NULL
molecule	NULL
may	NULL
be	NULL
recruited	NULL
to	NULL
the	NULL
u	NULL
enhancer	NULL
complex	NULL
via	NULL
interactions	NULL
with	NULL
appropriately	NULL
positioned	NULL
puA-	NULL
and	NULL
wB-binding	NULL
proteins	NULL
.	NULL

Although	NULL
synergistic	NULL
interactions	NULL
between	NULL
cis	NULL
elements	NULL
is	NULL
often	NULL
reflected	NULL
in	NULL
cooperative	NULL
DNA	NULL
binding	NULL
by	NULL
the	NULL
respective	NULL
trans-acting	NULL
factors	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
cooperative	NULL
binding	NULL
of	NULL
PU.1	NULL
and	NULL
Ets-1	NULL
to	NULL
m	NULL
enhancer	NULL
DNA	NULL
.	NULL

Because	NULL
the	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
bacterially	NULL
expressed	NULL
proteins	NULL
,	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
B-cell-specific	NULL
posttranslational	NULL
modifications	NULL
are	NULL
necessary	NULL
to	NULL
observe	NULL
such	NULL
effects	NULL
or	NULL
that	NULL
PU.1	NULL
or	NULL
Ets-1	NULL
functions	NULL
with	NULL
other	NULL
ETS-domain	NULL
genes	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Alternatively	NULL
,	NULL
our	NULL
observations	NULL
may	NULL
reflect	NULL
potential	NULL
synergistic	NULL
interactions	NULL
between	NULL
transcription	NULL
factors	NULL
at	NULL
a	NULL
level	NULL
other	NULL
than	NULL
DNA	NULL
binding	NULL
.	NULL

A	NULL
functional	NULL
role	NULL
for	NULL
protein-induced	NULL
DNA	NULL
bends	NULL
has	NULL
been	NULL
postulated	NULL
for	NULL
several	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
catabolite	NULL
activator	NULL
protein	NULL
(	NULL
62	NULL
)	NULL
,	NULL
LEF-1	NULL
(	NULL
13	NULL
)	NULL
,	NULL
retinoic	NULL
acid	NULL
receptors	NULL
(	NULL
34	NULL
,	NULL
36	NULL
)	NULL
,	NULL
YY-1	NULL
(	NULL
38	NULL
)	NULL
and	NULL
the	NULL
fos/jun	NULL
protein	NULL
family	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
of	NULL
the	NULL
three	NULL
factors	NULL
required	NULL
to	NULL
activate	NULL
the	NULL
minimal	NULL
p	NULL
enhancer	NULL
,	NULL
only	NULL
PU.1	NULL
induced	NULL
a	NULL
directed	NULL
bend	NULL
in	NULL
the	NULL
DNA	NULL
as	NULL
assayed	NULL
by	NULL
circular	NULL
permutation	NULL
and	NULL
phasing	NULL
analyses	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
binding	NULL
of	NULL
the	NULL
related	NULL
Ets-1	NULL
protein	NULL
does	NULL
not	NULL
bend	NULL
DNA	NULL
,	NULL
even	NULL
though	NULL
the	NULL
DNA	NULL
contacts	NULL
previously	NULL
defined	NULL
for	NULL
Ets-1	NULL
interaction	NULL
with	NULL
its	NULL
cognate	NULL
site	NULL
(	NULL
43	NULL
)	NULL
are	NULL
very	NULL
similar	NULL
to	NULL
those	NULL
made	NULL
by	NULL
PU.1	NULL
at	NULL
the	NULL
pB	NULL
site	NULL
(	NULL
45a	NULL
)	NULL
.	NULL

Our	NULL
observations	NULL
4552	NULL
NIKOLAJCZYK	NULL
ET	NULL
AL	NULL
.	NULL

1.1	NULL
T	NULL
T	NULL
NORMALIZED	NULL
MIGRATION	NULL
0.85	NULL
1	NULL
1	NULL
1	NULL
1	NULL
28	NULL
30	NULL
32	NULL
34	NULL
36	NULL
38	NULL
40	NULL
42	NULL
SPACER	NULL
LENGTH	NULL
(	NULL
bp	NULL
)	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

B	NULL
1.1	NULL
T	NULL
t	NULL
2	NULL
0	NULL
R	NULL
1.05	NULL
|-	NULL
m	NULL
3	NULL
1	NULL
F	NULL
6	NULL
e	NULL
a	NULL
U	NULL
u	NULL
N-	NULL
0.95	NULL
|-	NULL
=	NULL
_I	NULL
<	NULL
I	NULL
E	NULL
fa	NULL
]	NULL
0.9	NULL
Z	NULL
0.85	NULL
1	NULL
1	NULL
1	NULL
I	NULL
1	NULL
I	NULL
28	NULL
30	NULL
32	NULL
34	NULL
36	NULL
38	NULL
40	NULL
42	NULL
SPACER	NULL
LENGTH	NULL
(	NULL
bp	NULL
)	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Quantitation	NULL
of	NULL
directed	NULL
DNA	NULL
bend	NULL
angles	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
migration	NULL
of	NULL
individual	NULL
DNA-PU.1	NULL
complexes	NULL
normalized	NULL
to	NULL
the	NULL
average	NULL
migration	NULL
of	NULL
all	NULL
five	NULL
complexes	NULL
was	NULL
plotted	NULL
as	NULL
a	NULL
function	NULL
of	NULL
the	NULL
distance	NULL
between	NULL
the	NULL
center	NULL
GGAA	NULL
of	NULL
mB	NULL
and	NULL
the	NULL
center	NULL
of	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tracts	NULL
.	NULL

Data	NULL
from	NULL
three	NULL
experiments	NULL
are	NULL
shown	NULL
,	NULL
with	NULL
some	NULL
points	NULL
being	NULL
superimposed	NULL
.	NULL

The	NULL
best-fit	NULL
cosine	NULL
function	NULL
for	NULL
the	NULL
combined	NULL
data	NULL
was	NULL
obtained	NULL
by	NULL
using	NULL
KaliedaGraph	NULL
.	NULL

The	NULL
resulting	NULL
curve	NULL
demonstrates	NULL
a	NULL
periodicity	NULL
of	NULL
about	NULL
10.5	NULL
bp	NULL
,	NULL
as	NULL
expected	NULL
for	NULL
B-DNA	NULL
.	NULL

After	NULL
subtraction	NULL
of	NULL
the	NULL
horizontal	NULL
phase	NULL
shift	NULL
,	NULL
the	NULL
maxima	NULL
of	NULL
the	NULL
curve	NULL
are	NULL
at	NULL
approximately	NULL
0	NULL
and	NULL
10	NULL
bp	NULL
and	NULL
the	NULL
minimum	NULL
of	NULL
the	NULL
curve	NULL
lies	NULL
at	NULL
5	NULL
bp	NULL
.	NULL

ETS	NULL
(	NULL
PU.1	NULL
)	NULL
therefore	NULL
bends	NULL
DNA	NULL
toward	NULL
the	NULL
major	NULL
groove	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
best-fit	NULL
cosine	NULL
function	NULL
for	NULL
the	NULL
migration	NULL
of	NULL
DNA	NULL
phasing	NULL
probes	NULL
alone	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
demonstrates	NULL
an	NULL
insignificant	NULL
(	NULL
<	NULL
1.0°	NULL
)	NULL
intrinsic	NULL
bend	NULL
in	NULL
the	NULL
1	NULL
enhancer	NULL
DNA	NULL
phasing	NULL
probes	NULL
.	NULL

suggest	NULL
that	NULL
ETS	NULL
proteins	NULL
may	NULL
differ	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
induce	NULL
DNA	NULL
conformational	NULL
changes	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
DNA-bending	NULL
properties	NULL
may	NULL
determine	NULL
,	NULL
in	NULL
part	NULL
,	NULL
functional	NULL
differences	NULL
between	NULL
ETS	NULL
family	NULL
members	NULL
,	NULL
as	NULL
previously	NULL
proposed	NULL
for	NULL
bZip	NULL
family	NULL
proteins	NULL
(	NULL
26-28	NULL
)	NULL
.	NULL

Because	NULL
both	NULL
ETS-1	NULL
and	NULL
PU.1	NULL
proteins	NULL
recognize	NULL
their	NULL
sites	NULL
via	NULL
the	NULL
major	NULL
groove	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
PU.1-induced	NULL
bending	NULL
serves	NULL
to	NULL
align	NULL
the	NULL
two	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
uA	NULL
and	NULL
pB	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
Werner	NULL
et	NULL
al	NULL
.	NULL

(	NULL
59	NULL
)	NULL
described	NULL
a	NULL
high-resolution	NULL
structure	NULL
of	NULL
the	NULL
ETS	NULL
domain	NULL
of	NULL
Ets-1	NULL
bound	NULL
to	NULL
its	NULL
recognition	NULL
site	NULL
.	NULL

They	NULL
found	NULL
that	NULL
DNA	NULL
binding	NULL
by	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
induced	NULL
a	NULL
sharp	NULL
kink	NULL
in	NULL
the	NULL
DNA	NULL
as	NULL
a	NULL
result	NULL
of	NULL
local	NULL
compression	NULL
of	NULL
the	NULL
major	NULL
groove	NULL
and	NULL
widening	NULL
of	NULL
the	NULL
minor	NULL
groove	NULL
.	NULL

The	NULL
distortion	NULL
in	NULL
the	NULL
Ets-1/DNA	NULL
complex	NULL
is	NULL
caused	NULL
by	NULL
intercalation	NULL
of	NULL
a	NULL
tryptophan	NULL
residue	NULL
into	NULL
the	NULL
minor	NULL
groove	NULL
of	NULL
the	NULL
DNA	NULL
between	NULL
residues	NULL
6	NULL
and	NULL
7	NULL
of	NULL
the	NULL
Ets-1-binding	NULL
site	NULL
,	NULL
5	NULL
!	NULL

-TCGAGCCGG	NULL
AAGTTCGA-3	NULL
'	NULL
.	NULL

In	NULL
our	NULL
interpretation	NULL
of	NULL
the	NULL
PU.1	NULL
phasing	NULL
data	NULL
,	NULL
we	NULL
approximated	NULL
the	NULL
center	NULL
of	NULL
the	NULL
bend	NULL
to	NULL
the	NULL
site	NULL
of	NULL
a	NULL
Ets-1	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Model	NULL
for	NULL
the	NULL
functional	NULL
multiprotein	NULL
complex	NULL
on	NULL
the	NULL
minimal	NULL
p	NULL
enhancer	NULL
.	NULL

Ets-1	NULL
(	NULL
A-binding	NULL
protein	NULL
)	NULL
and	NULL
PU.1	NULL
(	NULL
.B-binding	NULL
protein	NULL
)	NULL
are	NULL
shown	NULL
bound	NULL
to	NULL
the	NULL
same	NULL
side	NULL
of	NULL
p	NULL
enhancer	NULL
DNA	NULL
,	NULL
with	NULL
the	NULL
smaller	NULL
circles	NULL
representing	NULL
the	NULL
ETS	NULL
domains	NULL
and	NULL
the	NULL
larger	NULL
circles	NULL
representing	NULL
the	NULL
non-DNA-binding	NULL
domains	NULL
of	NULL
each	NULL
protein	NULL
.	NULL

The	NULL
DNA	NULL
bend	NULL
of	NULL
approximately	NULL
24°	NULL
is	NULL
shown	NULL
directed	NULL
away	NULL
from	NULL
the	NULL
PU.1	NULL
protein	NULL
as	NULL
discussed	NULL
in	NULL
the	NULL
text	NULL
.	NULL

Formation	NULL
of	NULL
the	NULL
proposed	NULL
PU.1/Ets-1	NULL
interface	NULL
may	NULL
be	NULL
facilitated	NULL
by	NULL
the	NULL
PU.1-induced	NULL
DNA	NULL
bend	NULL
.	NULL

The	NULL
bHLH-zip	NULL
protein	NULL
TFE3	NULL
(	NULL
j.E3-binding	NULL
protein	NULL
)	NULL
interacts	NULL
with	NULL
the	NULL
DNA	NULL
from	NULL
the	NULL
opposite	NULL
side	NULL
of	NULL
the	NULL
helix	NULL
,	NULL
with	NULL
the	NULL
protein	NULL
located	NULL
behind	NULL
the	NULL
plane	NULL
of	NULL
the	NULL
paper	NULL
.	NULL

strong	NULL
PU.1-induced	NULL
DNase	NULL
I-hypersensitive	NULL
site	NULL
(	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
)	NULL
between	NULL
residues	NULL
5	NULL
and	NULL
6	NULL
of	NULL
the	NULL
pB	NULL
site	NULL
,	NULL
5'-T	NULL
ATTTGGGGAAGGGAA-3	NULL
'	NULL
.	NULL

The	NULL
close	NULL
correspondence	NULL
between	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
PU.1-induced	NULL
hypersensitive	NULL
site	NULL
and	NULL
Ets-l-induced	NULL
DNA	NULL
kinking	NULL
suggests	NULL
that	NULL
PU.1	NULL
binding	NULL
may	NULL
similarly	NULL
distort	NULL
the	NULL
DNA	NULL
helix	NULL
at	NULL
this	NULL
position	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
the	NULL
three	NULL
adenosine	NULL
residues	NULL
complementary	NULL
to	NULL
the	NULL
three	NULL
contiguous	NULL
thymidines	NULL
in	NULL
the	NULL
mB	NULL
site	NULL
score	NULL
strongly	NULL
in	NULL
methylation	NULL
interference	NULL
assays	NULL
(	NULL
45a	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
methyl	NULL
group	NULL
of	NULL
methyl	NULL
adenosines	NULL
falls	NULL
in	NULL
the	NULL
minor	NULL
groove	NULL
,	NULL
these	NULL
observations	NULL
suggest	NULL
that	NULL
PU.1	NULL
is	NULL
located	NULL
over	NULL
the	NULL
minor	NULL
groove	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
PU.1-induced	NULL
bend	NULL
.	NULL

Taken	NULL
together	NULL
with	NULL
the	NULL
phasing	NULL
analysis	NULL
that	NULL
shows	NULL
that	NULL
the	NULL
induced	NULL
bend	NULL
is	NULL
towards	NULL
the	NULL
major	NULL
groove	NULL
,	NULL
our	NULL
observations	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
DNA	NULL
being	NULL
bent	NULL
away	NULL
from	NULL
the	NULL
bound	NULL
PU.1	NULL
protein	NULL
.	NULL

This	NULL
facet	NULL
of	NULL
PU.1-DNA	NULL
interaction	NULL
is	NULL
also	NULL
consistent	NULL
with	NULL
the	NULL
proposed	NULL
structure	NULL
of	NULL
the	NULL
DNA	NULL
complex	NULL
(	NULL
59	NULL
)	NULL
and	NULL
highlights	NULL
the	NULL
similarity	NULL
of	NULL
DNA	NULL
recognition	NULL
by	NULL
these	NULL
distantly	NULL
related	NULL
ETS-domain	NULL
proteins	NULL
.	NULL

The	NULL
proposed	NULL
distortion	NULL
of	NULL
the	NULL
DNA	NULL
helix	NULL
may	NULL
facilitate	NULL
interactions	NULL
between	NULL
the	NULL
two	NULL
proteins	NULL
bound	NULL
at	NULL
the	NULL
uA	NULL
and	NULL
pB	NULL
sites	NULL
of	NULL
the	NULL
u	NULL
enhancer	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
observations	NULL
of	NULL
Werner	NULL
et	NULL
al	NULL
.	NULL

(	NULL
59	NULL
)	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
DNA	NULL
bending	NULL
by	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
in	NULL
circular	NULL
permutation	NULL
or	NULL
phasing	NULL
assays	NULL
.	NULL

One	NULL
possibility	NULL
for	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
results	NULL
of	NULL
the	NULL
two	NULL
studies	NULL
is	NULL
that	NULL
DNA	NULL
bending	NULL
would	NULL
be	NULL
more	NULL
evident	NULL
with	NULL
a	NULL
full-length	NULL
version	NULL
of	NULL
Ets-1	NULL
.	NULL

We	NULL
consider	NULL
this	NULL
unlikely	NULL
because	NULL
in	NULL
our	NULL
assays	NULL
DNA	NULL
bending	NULL
induced	NULL
by	NULL
the	NULL
ETS	NULL
domain	NULL
of	NULL
PU.1	NULL
was	NULL
identical	NULL
to	NULL
that	NULL
induced	NULL
by	NULL
the	NULL
full-length	NULL
protein	NULL
.	NULL

Alternatively	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
per	NULL
se	NULL
contributes	NULL
significantly	NULL
to	NULL
the	NULL
extent	NULL
of	NULL
DNA	NULL
bending	NULL
by	NULL
Ets-1	NULL
.	NULL

However	NULL
,	NULL
for	NULL
PU.1	NULL
protein	NULL
,	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
site	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
lesser	NULL
role	NULL
,	NULL
because	NULL
both	NULL
the	NULL
B-	NULL
and	NULL
the	NULL
substantially	NULL
different	NULL
SV40	NULL
PU.1-binding	NULL
sites	NULL
were	NULL
bent	NULL
to	NULL
a	NULL
similar	NULL
extent	NULL
upon	NULL
binding	NULL
this	NULL
protein	NULL
.	NULL

Lastly	NULL
,	NULL
the	NULL
mobility	NULL
shift	NULL
analysis	NULL
of	NULL
DNA	NULL
bending	NULL
may	NULL
not	NULL
be	NULL
sufficiently	NULL
sensitive	NULL
to	NULL
detect	NULL
the	NULL
small	NULL
(	NULL
10°	NULL
)	NULL
bend	NULL
induced	NULL
by	NULL
the	NULL
human	NULL
Ets-1	NULL
DNA-binding	NULL
domain	NULL
;	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
the	NULL
few	NULL
differences	NULL
between	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
Ets-1	NULL
proteins	NULL
further	NULL
reduces	NULL
the	NULL
bending	NULL
propensity	NULL
of	NULL
murine	NULL
Ets-1	NULL
.	NULL

Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
the	NULL
stereospecifically	NULL
precise	NULL
complex	NULL
generated	NULL
on	NULL
pA/uB	NULL
is	NULL
required	NULL
for	NULL
enhancer	NULL
activity	NULL
whether	NULL
the	NULL
E3	NULL
motif	NULL
is	NULL
being	NULL
utilized	NULL
(	NULL
as	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
p70	NULL
enhancer	NULL
)	NULL
or	NULL
not	NULL
(	NULL
as	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
p170	NULL
E3	NULL
en-hancer	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
p.	NULL
enhancer	NULL
is	NULL
driven	NULL
by	NULL
an	NULL
ETS	NULL
protein-containing	NULL
nucleoprotein	NULL
complex	NULL
which	NULL
serves	NULL
as	NULL
an	NULL
enhancer	NULL
core	NULL
with	NULL
the	NULL
ability	NULL
to	NULL
utilize	NULL
proximal	NULL
p	NULL
enhancer	NULL
elements	NULL
,	NULL
such	NULL
as	NULL
E	NULL
motifs	NULL
,	NULL
to	NULL
activate	NULL
transcription	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Batu	NULL
Erman	NULL
for	NULL
providing	NULL
ETS	NULL
(	NULL
Ets-1	NULL
)	NULL
and	NULL
the	NULL
three-dimensional	NULL
p	NULL
enhancer	NULL
model	NULL
;	NULL
Kathryn	NULL
Calame	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
N.Y.	NULL
,	NULL
for	NULL
providing	NULL
bacterial	NULL
expression	NULL
vectors	NULL
for	NULL
GST.TFE3	NULL
and	NULL
GST.TFE3S	NULL
;	NULL
Tom	NULL
Kerppola	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
for	NULL
providing	NULL
the	NULL
phasing	NULL
vectors	NULL
;	NULL
A.	NULL
Landy	NULL
,	NULL
Brown	NULL
University	NULL
,	NULL
Providence	NULL
,	NULL
RL	NULL
.	NULL

,	NULL
for	NULL
providing	NULL
the	NULL
A	NULL
tract	NULL
standards	NULL
;	NULL
James	NULL
Falvo	NULL
,	NULL
Harvard	NULL
University	NULL
,	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL

,	NULL
for	NULL
assistance	NULL
with	NULL
phasing	NULL
analysis	NULL
;	NULL
and	NULL
Margaret	NULL
Baron	NULL
and	NULL
Laura	NULL
Cabaniss	NULL
for	NULL
reading	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
NIH	NULL
(	NULL
GM	NULL
38925	NULL
)	NULL
and	NULL
the	NULL
March	NULL
of	NULL
Dimes	NULL
Birth	NULL
Defects	NULL
Foundation	NULL
to	NULL
R.S	NULL
.	NULL

B.N	NULL
.	NULL

is	NULL
a	NULL
recipient	NULL
of	NULL
a	NULL
National	NULL
Research	NULL
Service	NULL
Award	NULL
(	NULL
HD	NULL
07653	NULL
)	NULL
and	NULL
an	NULL
Arthritis	NULL
Foundation	NULL
postdoctoral	NULL
fellowship	NULL
.	NULL

R.S	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
Research	NULL
Career	NULL
Development	NULL
Award	NULL
(	NULL
GM	NULL
00563	NULL
)	NULL
from	NULL
the	NULL
NIH	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Alessandrini	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
S.	NULL
V.	NULL
Desiderio	NULL
.	NULL

1991	NULL
.	NULL

Coordination	NULL
of	NULL
immunoglobulin	NULL
DJy	NULL
,	NULL
transcription	NULL
and	NULL
D-to-Jp	NULL
rearrangement	NULL
by	NULL
promoter-enhancer	NULL
ap-proximation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:2096-2107	NULL
.	NULL

2	NULL
.	NULL

Bain	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
C.	NULL
R.	NULL
Maandag	NULL
,	NULL
D.	NULL
J.	NULL
Izon	NULL
,	NULL
D.	NULL
Amsen	NULL
,	NULL
A.	NULL
M.	NULL
Kruisbeek	NULL
,	NULL
B.	NULL
C.	NULL
Weintraub	NULL
,	NULL
I.	NULL
Krop	NULL
,	NULL
M.	NULL
S.	NULL
Schlissel	NULL
,	NULL
A.	NULL
J.	NULL
Feeney	NULL
,	NULL
M.	NULL
van	NULL
Roon	NULL
,	NULL
M.	NULL
van	NULL
der	NULL
Valk	NULL
,	NULL
H.	NULL
P.	NULL
J.	NULL
ter	NULL
Riele	NULL
,	NULL
A.	NULL
Berns	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1994	NULL
.	NULL

E2A	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
proper	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
initiation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
rearrangements	NULL
.	NULL

Cell	NULL
79:885-892	NULL
.	NULL

3	NULL
.	NULL

Beckmann	NULL
,	NULL
H.	NULL
,	NULL
L-K.	NULL
Su	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1990	NULL
.	NULL

TFE3	NULL
:	NULL
A	NULL
helix-loop-helix	NULL
protein	NULL
that	NULL
activates	NULL
transcription	NULL
through	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
wE3	NULL
motif	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4167-179	NULL
.	NULL

4	NULL
.	NULL

Blackwell	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
J.	NULL
Huang	NULL
,	NULL
A.	NULL
Ma	NULL
,	NULL
L.	NULL
Kretzner	NULL
,	NULL
F.	NULL
W.	NULL
Alt	NULL
,	NULL
R.	NULL
N.	NULL
Eisenman	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1993	NULL
.	NULL

Binding	NULL
of	NULL
Myc	NULL
proteins	NULL
to	NULL
canonical	NULL
and	NULL
nonca-nonical	NULL
DNA	NULL
sequences	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:5216-5224	NULL
.	NULL

5	NULL
.	NULL

Blackwell	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
M.	NULL
W.	NULL
Moore	NULL
,	NULL
G.	NULL
D.	NULL
Yancopoulos	NULL
,	NULL
H.	NULL
Suh	NULL
,	NULL
S.	NULL
Lutzker	NULL
,	NULL
E.	NULL
Selsing	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Alt	NULL
.	NULL

1986	NULL
.	NULL

Recombination	NULL
between	NULL
immunoglobulin	NULL
variable	NULL
region	NULL
gene	NULL
segments	NULL
is	NULL
enhanced	NULL
by	NULL
transcription	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
324:585-589	NULL
.	NULL

6	NULL
.	NULL

Bruggemann	NULL
,	NULL
M.	NULL
,	NULL
J	NULL
.	NULL

Free	NULL
,	NULL
A.	NULL
Diamond	NULL
,	NULL
J.	NULL
Howard	NULL
,	NULL
S.	NULL
Cobbold	NULL
,	NULL
and	NULL
H.	NULL
Waldmann	NULL
.	NULL

1986	NULL
.	NULL

Immunoglobulin	NULL
heavy	NULL
chain	NULL
locus	NULL
of	NULL
the	NULL
rat	NULL
:	NULL
striking	NULL
homology	NULL
to	NULL
mouse	NULL
antibody	NULL
genes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:6075-6079	NULL
.	NULL

7	NULL
.	NULL

Carr	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
helix-loop-helix	NULL
protein	NULL
related	NULL
to	NULL
the	NULL
immunoglobulin	NULL
E	NULL
box-binding	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:4384-4388	NULL
.	NULL

8	NULL
.	NULL

Chen	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
Young	NULL
,	NULL
A.	NULL
Bottaro	NULL
,	NULL
V.	NULL
Stewart	NULL
,	NULL
R.	NULL
K.	NULL
Smith	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Alt	NULL
.	NULL

1993	NULL
.	NULL

Mutations	NULL
of	NULL
the	NULL
intronic	NULL
IgH	NULL
enhancer	NULL
and	NULL
its	NULL
flanking	NULL
sequences	NULL
differen-tially	NULL
affect	NULL
accessibility	NULL
of	NULL
the	NULL
Jy	NULL
locus	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:4635-4645	NULL
.	NULL

9	NULL
.	NULL

Ephrussi	NULL
,	NULL
A.	NULL
,	NULL
G.	NULL
M.	NULL
Church	NULL
,	NULL
S.	NULL
Tonegawa	NULL
,	NULL
and	NULL
W.	NULL
Gilbert	NULL
.	NULL

1985	NULL
.	NULL

B	NULL
lincage-specific	NULL
interactions	NULL
of	NULL
an	NULL
immunoglobulin	NULL
enhancer	NULL
with	NULL
cellular	NULL
factors	NULL
in	NULL
vivo	NULL
.	NULL

Science	NULL
227:134-140	NULL
.	NULL

9a.Erman	NULL
,	NULL
B	NULL
.	NULL

Personal	NULL
communication	NULL
.	NULL

10	NULL
.	NULL

Fernex	NULL
,	NULL
C.	NULL
,	NULL
M.	NULL
Capone	NULL
,	NULL
and	NULL
P.	NULL
Ferrier	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombinational	NULL
and	NULL
transcriptional	NULL
activities	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
intronic	NULL
enhancer	NULL
can	NULL
be	NULL
mediated	NULL
through	NULL
distinct	NULL
protein-binding	NULL
sites	NULL
in	NULL
a	NULL
transgenic	NULL
substrate	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:3217-3226	NULL
.	NULL

11	NULL
.	NULL

Fisher	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

Parent	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1992	NULL
.	NULL

Myc/max	NULL
and	NULL
other	NULL
helix-loop-helix/leucine	NULL
zipper	NULL
proteins	NULL
bend	NULL
DNA	NULL
toward	NULL
the	NULL
minor	NULL
groove	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:11779-11783	NULL
.	NULL

12	NULL
.	NULL

Genetta	NULL
,	NULL
T.	NULL
,	NULL
D.	NULL
Ruezinsky	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1994	NULL
.	NULL

Displacement	NULL
of	NULL
an	NULL
E-box-binding	NULL
repressor	NULL
by	NULL
basic	NULL
helix-loop-helix	NULL
proteins	NULL
:	NULL
implications	NULL
for	NULL
B-cell	NULL
specificity	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6153-6163	NULL
.	NULL

13	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
Cox	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
HMG	NULL
domain	NULL
of	NULL
lymphoid	NULL
enhancer	NULL
factor	NULL
1	NULL
bends	NULL
DNA	NULL
and	NULL
facilitates	NULL
assembly	NULL
of	NULL
functional	NULL
nucleoprotein	NULL
structures	NULL
.	NULL

Cell	NULL
69:185-195	NULL
.	NULL

14	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Kingsley	NULL
,	NULL
J.	NULL
R.	NULL
Kirshner	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1995	NULL
.	NULL

Assembly	NULL
and	NULL
function	NULL
of	NULL
a	NULL
TCRa	NULL
enhancer	NULL
complex	NULL
is	NULL
dependent	NULL
on	NULL
LEF-1-induced	NULL
DNA	NULL
bending	NULL
and	NULL
multiple	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:995-1008	NULL
.	NULL

15	NULL
.	NULL

Gilman	NULL
,	NULL
M.	NULL
Z.	NULL
,	NULL
R.	NULL
N.	NULL
Wilson	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Weinberg	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
protein	NULL
w	NULL
ENHANCER	NULL
ACTIVATION	NULL
REQUIRES	NULL
SITE	NULL
ALIGNMENT	NULL
16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

4553	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
5'-flanking	NULL
region	NULL
regulate	NULL
c-fos	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

64305-4316	NULL
.	NULL

Gregor	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
M.	NULL
Sawadogo	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
adenovirus	NULL
major	NULL
late	NULL
transcription	NULL
factor	NULL
USF	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
helix-loop-helix	NULL
group	NULL
of	NULL
regulatory	NULL
proteins	NULL
and	NULL
binds	NULL
to	NULL
DNA	NULL
as	NULL
a	NULL
dimer	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1730-1740	NULL
.	NULL

Grossched	NULL
]	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1985	NULL
.	NULL

Cell	NULL
type	NULL
specificity	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
at	NULL
least	NULL
three	NULL
DNA	NULL
sequence	NULL
elements	NULL
.	NULL

Cell	NULL
41:885-897	NULL
.	NULL

Hagman	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
GrosschedlI	NULL
.	NULL

1992	NULL
.	NULL

An	NULL
inhibitory	NULL
carboxyl-terminal	NULL
domain	NULL
in	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
mediates	NULL
differential	NULL
binding	NULL
of	NULL
ETS	NULL
family	NULL
factors	NULL
to	NULL
promoter	NULL
sequences	NULL
of	NULL
the	NULL
mb-7	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
:	NULL
8889-8893	NULL
.	NULL

Hanson	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
J.	NULL
L.	NULL
Grisolano	NULL
,	NULL
and	NULL
T.	NULL
J.	NULL
Ley	NULL
.	NULL

1993	NULL
.	NULL

Consensus	NULL
AP-1	NULL
and	NULL
CRE	NULL
motifs	NULL
upstream	NULL
from	NULL
the	NULL
human	NULL
cytotoxic	NULL
serine	NULL
protease	NULL
B	NULL
(	NULL
CSP-B/	NULL
CGL-1	NULL
)	NULL
gene	NULL
synergize	NULL
to	NULL
activate	NULL
transcription	NULL
.	NULL

Blood	NULL
82:2749-2757	NULL
.	NULL

Hayday	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
S.	NULL
D.	NULL
Gillies	NULL
,	NULL
H.	NULL
Saito	NULL
,	NULL
C.	NULL
Wood	NULL
,	NULL
K.	NULL
Wiman	NULL
,	NULL
W.	NULL
S.	NULL
Hayward	NULL
,	NULL
and	NULL
S.	NULL
Tonegawa	NULL
.	NULL

1984	NULL
.	NULL

Activation	NULL
of	NULL
a	NULL
translocated	NULL
human	NULL
c-myc	NULL
gene	NULL
by	NULL
an	NULL
enhancer	NULL
in	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
locus	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
307	NULL
:	NULL
334-340	NULL
.	NULL

Hernandez-Munain	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Krangel	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
and	NULL
enhancer	NULL
by	NULL
functional	NULL
cooperation	NULL
between	NULL
c-Myb	NULL
and	NULL
core-binding	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:473-483	NULL
.	NULL

Ho	NULL
,	NULL
I.-C.	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
a	NULL
gene	NULL
enhancer	NULL
:	NULL
multiple	NULL
ubiquitous	NULL
and	NULL
T-cell-specific	NULL
nuclear	NULL
proteins	NULL
interact	NULL
with	NULL
four	NULL
hypomethylated	NULL
enhancer	NULL
elements	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
:	NULL
4720-4727	NULL
.	NULL

Jenuwein	NULL
,	NULL
T.	NULL
,	NULL
W.	NULL
C.	NULL
Forrester	NULL
,	NULL
R.-G.	NULL
Qiu	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
,	NULL
1993	NULL
.	NULL

The	NULL
immunoglobulin	NULL
p	NULL
enhancer	NULL
core	NULL
establishes	NULL
local	NULL
factor	NULL
access	NULL
in	NULL
nuclear	NULL
chromatin	NULL
independent	NULL
of	NULL
transcriptional	NULL
stimulation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2016-2032	NULL
.	NULL

Kadesch	NULL
,	NULL
T.	NULL
,	NULL
P.	NULL
Zervos	NULL
,	NULL
and	NULL
D.	NULL
Ruezinsky	NULL
.	NULL

1986	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
murine	NULL
IgH	NULL
enhancer	NULL
:	NULL
evidence	NULL
for	NULL
negative	NULL
control	NULL
of	NULL
cell-type	NULL
specificity	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14:8209-8221	NULL
.	NULL

Karim	NULL
,	NULL
F.	NULL
D.	NULL
,	NULL
L.	NULL
D.	NULL
Urness	NULL
,	NULL
C.	NULL
S.	NULL
Thummel	NULL
,	NULL
M.	NULL
J.	NULL
Klemsz	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
C.	NULL
VanBeveren	NULL
,	NULL
R.	NULL
A.	NULL
Maki	NULL
,	NULL
C.	NULL
V.	NULL
Gunther	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Nye	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
ETS-domain	NULL
:	NULL
a	NULL
new	NULL
DNA-binding	NULL
motif	NULL
that	NULL
recognizes	NULL
a	NULL
purine-rich	NULL
core	NULL
DNA	NULL
sequence	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

41451-1453	NULL
.	NULL

Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
and	NULL
T.	NULL
Curran	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
bending	NULL
by	NULL
fos	NULL
and	NULL
jun	NULL
:	NULL
the	NULL
flexible	NULL
hinge	NULL
model	NULL
.	NULL

Science	NULL
254:1210-1214	NULL
.	NULL

Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
and	NULL
T.	NULL
Curran	NULL
.	NULL

1991	NULL
.	NULL

Fos-jun	NULL
heterodimers	NULL
and	NULL
jun	NULL
ho-modimers	NULL
bend	NULL
DNA	NULL
in	NULL
opposite	NULL
orientations	NULL
:	NULL
implications	NULL
for	NULL
transcription	NULL
factor	NULL
cooperativity	NULL
.	NULL

Cell	NULL
66:317-326	NULL
.	NULL

Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
and	NULL
T.	NULL
Curran	NULL
.	NULL

1993	NULL
.	NULL

Selective	NULL
DNA	NULL
bending	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
bZIP	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:5479-5489	NULL
.	NULL

Kim	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Zwieb	NULL
,	NULL
C.	NULL
Wu	NULL
,	NULL
and	NULL
S.	NULL
Adhya	NULL
.	NULL

1989	NULL
.	NULL

Bending	NULL
of	NULL
DNA	NULL
by	NULL
gene-regulatory	NULL
proteins	NULL
:	NULL
construction	NULL
and	NULL
use	NULL
of	NULL
a	NULL
DNA	NULL
bending	NULL
vector	NULL
.	NULL

Gene	NULL
85:15-23	NULL
.	NULL

Lee	NULL
,	NULL
D.-H.	NULL
,	NULL
and	NULL
R.	NULL
F.	NULL
Schleif	NULL
.	NULL

1989	NULL
.	NULL

In	NULL
vivo	NULL
DNA	NULL
loops	NULL
in	NULL
areCBAD	NULL
:	NULL
size	NULL
limits	NULL
and	NULL
helical	NULL
repeat	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:476-480	NULL
.	NULL

Lennon	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
and	NULL
R.	NULL
P.	NULL
Perry	NULL
.	NULL

1985	NULL
.	NULL

Cu-containing	NULL
transcripts	NULL
initiate	NULL
heterogencously	NULL
within	NULL
the	NULL
IgH	NULL
enhancer	NULL
region	NULL
and	NULL
contain	NULL
a	NULL
novel	NULL
5'-nontranslatable	NULL
exon	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
318:475-478	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
W.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Aspects	NULL
Cell	NULL
.	NULL

Regul	NULL
.	NULL

6:399-421	NULL
.	NULL

Lim	NULL
,	NULL
F.	NULL
,	NULL
N.	NULL
Kraut	NULL
,	NULL
J.	NULL
Frampton	NULL
,	NULL
and	NULL
T.	NULL
Graf	NULL
.	NULL

1992	NULL
.	NULL

DNA	NULL
binding	NULL
by	NULL
c-Ets-1	NULL
,	NULL
but	NULL
not	NULL
v-Ets	NULL
,	NULL
is	NULL
repressed	NULL
by	NULL
an	NULL
intramolecular	NULL
mechanism	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:643-652	NULL
.	NULL

Lu	NULL
,	NULL
X.	NULL
P.	NULL
,	NULL
N.	NULL
L.	NULL
Eberhardt	NULL
,	NULL
and	NULL
M.	NULL
Pfahl	NULL
.	NULL

1993	NULL
.	NULL

DNA	NULL
bending	NULL
by	NULL
retinoid	NULL
X	NULL
receptor-containing	NULL
retinoid	NULL
and	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
complexes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:6509-6519	NULL
.	NULL

Mage	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Newman	NULL
,	NULL
N.	NULL
Harindranath	NULL
,	NULL
K.	NULL
E.	NULL
Bernstein	NULL
,	NULL
R.	NULL
S.	NULL
Becker	NULL
,	NULL
and	NULL
K.	NULL
L.	NULL
Knight	NULL
.	NULL

1989	NULL
.	NULL

Evolutionary	NULL
conservation	NULL
of	NULL
splice	NULL
sites	NULL
in	NULL
sterile	NULL
Cp	NULL
transcripts	NULL
and	NULL
of	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
(	NULL
IgH	NULL
)	NULL
enhancer	NULL
region	NULL
sequences	NULL
.	NULL

Mol	NULL
.	NULL

Immunol	NULL
.	NULL

26:1007-1010	NULL
.	NULL

McBroom	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
G.	NULL
Flock	NULL
,	NULL
and	NULL
V.	NULL
Giguére	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
nonconserved	NULL
hinge	NULL
region	NULL
and	NULL
distinct	NULL
amino-terminal	NULL
domains	NULL
of	NULL
the	NULL
ROR	NULL
orphan	NULL
nuclear	NULL
receptor	NULL
isoforms	NULL
are	NULL
required	NULL
for	NULL
proper	NULL
DNA	NULL
bending	NULL
and	NULL
RORa-DNA	NULL
interactions	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:796-808	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
S.	NULL
McCaw	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
new	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
motif	NULL
in	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
,	NULL
daughterless	NULL
,	NULL
MyoD	NULL
,	NULL
and	NULL
myc	NULL
proteins	NULL
.	NULL

Cell	NULL
56:777-783	NULL
.	NULL

Natesan	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
Z.	NULL
Gilman	NULL
.	NULL

1993	NULL
.	NULL

DNA	NULL
bending	NULL
and	NULL
orientation-depen-dent	NULL
function	NULL
of	NULL
YY1	NULL
in	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2497-2509	NULL
.	NULL

Nelsen	NULL
,	NULL
B.	NULL
,	NULL
L.	NULL
Hellman	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1988	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
mediates	NULL
phorbol	NULL
ester-inducible	NULL
transcription	NULL
in	NULL
non-lymphoid	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:3526-3531	NULL
.	NULL

Nelsen	NULL
,	NULL
B.	NULL
,	NULL
T.	NULL
Kadesch	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1990	NULL
.	NULL

Complex	NULL
regulation	NULL
of	NULL
the	NULL
immunoglobulin	NULL
p.	NULL
heavy-chain	NULL
gene	NULL
enhancer	NULL
:	NULL
pB	NULL
,	NULL
a	NULL
new	NULL
determinant	NULL
of	NULL
enhancer	NULL
function	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:3145-3154	NULL
.	NULL

Nelsen	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1992	NULL
.	NULL

Regulation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
transcription	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

133:121-149	NULL
.	NULL

Nelsen	NULL
,	NULL
B.	NULL
,	NULL
G.	NULL
Tian	NULL
,	NULL
B.	NULL
Erman	NULL
,	NULL
J.	NULL
Gregoire	NULL
,	NULL
R.	NULL
Maki	NULL
,	NULL
B.	NULL
Graves	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
4554	NULL
43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

NIKOLAJCZYK	NULL
ET	NULL
AL	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
lymphoid-specific	NULL
immunoglobulin	NULL
p	NULL
heavy	NULL
chain	NULL
gene	NULL
enhancer	NULL
by	NULL
ETS-domain	NULL
proteins	NULL
.	NULL

Science	NULL
261:82-86	NULL
.	NULL

Nye	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
Petersen	NULL
,	NULL
C.	NULL
V.	NULL
Gunther	NULL
,	NULL
M.	NULL
D.	NULL
Jonsen	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
of	NULL
murine	NULL
Ets-1	NULL
with	NULL
GGA-binding	NULL
sites	NULL
establishes	NULL
the	NULL
ETS	NULL
domain	NULL
as	NULL
a	NULL
new	NULL
DNA-binding	NULL
motif	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:975-990	NULL
.	NULL

Oltz	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
F.	NULL
W.	NULL
Alt	NULL
,	NULL
W.-C.	NULL
Lin	NULL
,	NULL
J.	NULL
Chen	NULL
,	NULL
G.	NULL
Taccioli	NULL
,	NULL
S.	NULL
Desiderio	NULL
,	NULL
and	NULL
G.	NULL
Rathbun	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombinase-inducible	NULL
B-cell	NULL
line	NULL
:	NULL
role	NULL
of	NULL
transcriptional	NULL
enhancer	NULL
elements	NULL
in	NULL
directing	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:6223-6230	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
N.	NULL
L.	NULL
Edwards	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Agranoff	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
cooperative	NULL
interaction	NULL
between	NULL
NF-kB	NULL
and	NULL
Sp1	NULL
is	NULL
required	NULL
for	NULL
HIV-1	NULL
enhancer	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3551-3558	NULL
.	NULL

45a.Rao	NULL
,	NULL
E.	NULL
,	NULL
W.	NULL
Dang	NULL
,	NULL
G.	NULL
Tian	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
A	NULL
three	NULL
protein	NULL
DNA	NULL
complex	NULL
46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51.	NULL
defines	NULL
a	NULL
functional	NULL
unit	NULL
of	NULL
the	NULL
lymphoid-specific	NULL
immunoglobulin	NULL
j.	NULL
heavy	NULL
chain	NULL
gene	NULL
enhancer	NULL
.	NULL

Submitted	NULL
for	NULL
publication	NULL
.	NULL

Rivera	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
M.	NULL
H.	NULL
Stuiver	NULL
,	NULL
R.	NULL
Steenbergen	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1993	NULL
.	NULL

Ets	NULL
proteins	NULL
:	NULL
new	NULL
factors	NULL
that	NULL
regulate	NULL
immunoglobuin	NULL
heavy-chain	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:7163-7169	NULL
.	NULL

Roman	NULL
,	NULL
C.	NULL
,	NULL
L.	NULL
Cohn	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
dominant	NULL
negative	NULL
form	NULL
of	NULL
transcription	NULL
activator	NULL
mTFE3	NULL
created	NULL
by	NULL
differential	NULL
splicing	NULL
.	NULL

Science	NULL
254	NULL
:	NULL
94-97	NULL
.	NULL

Roman	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
G.	NULL
Matera	NULL
,	NULL
C.	NULL
Cooper	NULL
,	NULL
S.	NULL
Artandi	NULL
,	NULL
S.	NULL
Blain	NULL
,	NULL
D.	NULL
C.	NULL
Ward	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1992.	NULL
mTFE3	NULL
,	NULL
an	NULL
X-linked	NULL
transcriptional	NULL
activator	NULL
containing	NULL
basic	NULL
helix-loop-helix	NULL
and	NULL
zipper	NULL
domains	NULL
,	NULL
utilizes	NULL
the	NULL
zipper	NULL
to	NULL
stabilize	NULL
both	NULL
DNA	NULL
binding	NULL
and	NULL
multimerization	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:817-827	NULL
.	NULL

Ruezinsky	NULL
,	NULL
D.	NULL
,	NULL
H.	NULL
Beckmann	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1991	NULL
.	NULL

Modulation	NULL
of	NULL
the	NULL
IgH	NULL
enhancer	NULL
's	NULL
cell	NULL
type	NULL
specificity	NULL
through	NULL
a	NULL
genetic	NULL
switch	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:29-37	NULL
.	NULL

Schanke	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
B.	NULL
G.	NULL
VanNess	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
organization	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
x	NULL
Ig	NULL
intron	NULL
enhancer	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:4565-4572	NULL
.	NULL

Serwe	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
F.	NULL
Sablitzky	NULL
.	NULL

1993	NULL
.	NULL

V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
in	NULL
B	NULL
cells	NULL
is	NULL
impaired	NULL
but	NULL
not	NULL
blocked	NULL
by	NULL
targeted	NULL
deletion	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

chain	NULL
intron	NULL
enhancer	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:2321-2327	NULL
.	NULL

Shen	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Lieberman	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Eckhardt	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
octamer/pF4	NULL
region	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
mediates	NULL
gene	NULL
repression	NULL
in	NULL
myeloma	NULL
X	NULL
T-lymphoma	NULL
hybrids	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3530-3540	NULL
.	NULL

Smith	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
and	NULL
K.	NULL
S.	NULL
Johnson	NULL
.	NULL

1988	NULL
.	NULL

Single-step	NULL
purification	NULL
of	NULL
polypep-tides	NULL
expressed	NULL
in	NULL
Escherichia	NULL
col	NULL
as	NULL
fusions	NULL
with	NULL
glutathione	NULL
S-transferase	NULL
.	NULL

Gene	NULL
67:31-40	NULL
.	NULL

Sun	NULL
,	NULL
S.-H.	NULL
1994	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
the	NULL
I4	NULL
]	NULL
gene	NULL
impairs	NULL
mouse	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

Cell	NULL
79:893-900	NULL
.	NULL

Takahashi	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Vigneron	NULL
,	NULL
H.	NULL
Mattes	NULL
,	NULL
A.	NULL
Wildeman	NULL
,	NULL
M.	NULL
Zenke	NULL
,	NULL
and	NULL
P.	NULL
Chambon	NULL
.	NULL

1986	NULL
.	NULL

Requirement	NULL
of	NULL
stereospecific	NULL
alignments	NULL
for	NULL
initiation	NULL
from	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
promoter	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
319:121-126	NULL
.	NULL

Thompson	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
A.	NULL
Landy	NULL
.	NULL

1988	NULL
.	NULL

Empirical	NULL
estimation	NULL
of	NULL
protein-induced	NULL
DNA	NULL
bending	NULL
angles	NULL
:	NULL
applications	NULL
to	NULL
\	NULL
site-specific	NULL
recombination	NULL
complexes	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16:9687-9705	NULL
.	NULL

Vilen	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
J.	NULL
P.	NULL
Cogswell	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Ting	NULL
.	NULL

1991	NULL
.	NULL

Stereospecific	NULL
alignment	NULL
of	NULL
the	NULL
X	NULL
and	NULL
Y	NULL
elements	NULL
is	NULL
required	NULL
for	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
DRA	NULL
promoter	NULL
function	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:2406-2415	NULL
.	NULL

Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
J.-P.	NULL
Kerckaert	NULL
,	NULL
and	NULL
B.	NULL
Wasylyk	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
modulator	NULL
domain	NULL
of	NULL
Ets	NULL
transcription	NULL
factors	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:965-974	NULL
.	NULL

Werner	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
G.	NULL
M.	NULL
Clore	NULL
,	NULL
C.	NULL
L.	NULL
Fisher	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
L.	NULL
Trinh	NULL
,	NULL
J.	NULL
Shiloach	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Gronenborn	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
solution	NULL
structure	NULL
of	NULL
the	NULL
human	NULL
ETS1-DNA	NULL
complex	NULL
reveals	NULL
a	NULL
novel	NULL
mode	NULL
of	NULL
binding	NULL
and	NULL
true	NULL
side	NULL
chain	NULL
interca-lation	NULL
.	NULL

Cell	NULL
83:761-771	NULL
.	NULL

Wooton	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
S.	NULL
Wang	NULL
,	NULL
N.	NULL
A.	NULL
Speck	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Owen	NULL
.	NULL

1994	NULL
.	NULL

Cooperative	NULL
binding	NULL
of	NULL
Ets-1	NULL
and	NULL
core	NULL
binding	NULL
factor	NULL
to	NULL
DNA	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:840-850	NULL
.	NULL

Zhuang	NULL
,	NULL
Y.	NULL
,	NULL
P.	NULL
Soriano	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
helix-loop-helix	NULL
gene	NULL
E2A	NULL
is	NULL
required	NULL
for	NULL
B	NULL
cell	NULL
formation	NULL
.	NULL

Cell	NULL
79:875-884	NULL
.	NULL

Zinkel	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Crothers	NULL
.	NULL

1991	NULL
.	NULL

Catabolite	NULL
activator	NULL
protein-induced	NULL
DNA	NULL
bending	NULL
in	NULL
transcription	NULL
initiation	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

219:201-215	NULL
.	NULL

